<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://darebioscience.com/role/Acquisitions" xlink:href="dare-20190630.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/AcquisitionsAdditionalInformationDetail" xlink:href="dare-20190630.xsd#AcquisitionsAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/CommitmentsAndContingencies" xlink:href="dare-20190630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="dare-20190630.xsd#CommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedBalanceSheets" xlink:href="dare-20190630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="dare-20190630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="dare-20190630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="dare-20190630.xsd#ConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="dare-20190630.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/DocumentAndEntityInformation" xlink:href="dare-20190630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/GoingConcern" xlink:href="dare-20190630.xsd#GoingConcern" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/GoingConcernAdditionalInformationDetail" xlink:href="dare-20190630.xsd#GoingConcernAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/GrantAward" xlink:href="dare-20190630.xsd#GrantAward" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/GrantAwardAdditionalInformationDetail" xlink:href="dare-20190630.xsd#GrantAwardAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedProperties" xlink:href="dare-20190630.xsd#LeasedProperties" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedPropertiesDetails" xlink:href="dare-20190630.xsd#LeasedPropertiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedPropertiesLeasedPropertiesFutureMinimumLeasePaymentsDetails" xlink:href="dare-20190630.xsd#LeasedPropertiesLeasedPropertiesFutureMinimumLeasePaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedPropertiesTables" xlink:href="dare-20190630.xsd#LeasedPropertiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/NetLossPerShare" xlink:href="dare-20190630.xsd#NetLossPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/NetLossPerSharePotentialDilutiveOutstandingSecuritiesExcludedFromDilutedNetLossPerCommonShareDetail" xlink:href="dare-20190630.xsd#NetLossPerSharePotentialDilutiveOutstandingSecuritiesExcludedFromDilutedNetLossPerCommonShareDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/NetLossPerShareTables" xlink:href="dare-20190630.xsd#NetLossPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/OrganizationAndDescriptionOfBusiness" xlink:href="dare-20190630.xsd#OrganizationAndDescriptionOfBusiness" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/OrganizationAndDescriptionOfBusinessAdditionalInformationDetail" xlink:href="dare-20190630.xsd#OrganizationAndDescriptionOfBusinessAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensation" xlink:href="dare-20190630.xsd#StockBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:href="dare-20190630.xsd#StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesOptionPricingModelForStockOptionsGrantedToEmployeesAndDirectorsDetail" xlink:href="dare-20190630.xsd#StockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesOptionPricingModelForStockOptionsGrantedToEmployeesAndDirectorsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensationSummaryOfRecognizedStockBasedCompensationExpenseRelatedToStockOptionsGrantedToEmployeesAndDirectorsDetails" xlink:href="dare-20190630.xsd#StockBasedCompensationSummaryOfRecognizedStockBasedCompensationExpenseRelatedToStockOptionsGrantedToEmployeesAndDirectorsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensationSummaryOfStockOptionActivityForAmended2014PlanAndRelatedInformationDetail" xlink:href="dare-20190630.xsd#StockBasedCompensationSummaryOfStockOptionActivityForAmended2014PlanAndRelatedInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensationTables" xlink:href="dare-20190630.xsd#StockBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquity" xlink:href="dare-20190630.xsd#StockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquityAdditionalInformationDetail" xlink:href="dare-20190630.xsd#StockholdersEquityAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquityScheduleOfCommonStockWarrantsOutstandingDetails" xlink:href="dare-20190630.xsd#StockholdersEquityScheduleOfCommonStockWarrantsOutstandingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquityTables" xlink:href="dare-20190630.xsd#StockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="dare-20190630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="dare-20190630.xsd#SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="dare-20190630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://darebioscience.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_F3EEE77E34E351E5AB00312CB74B7A08" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_0F170CA403F552A4AD51E9DB2E0294A3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_F3EEE77E34E351E5AB00312CB74B7A08" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_0F170CA403F552A4AD51E9DB2E0294A3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/AcquisitionsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_5D0E7B7B0D915F63682678071B324D6E" xlink:type="locator" />
    <link:loc xlink:href="dare-20190630.xsd#dare_ScheduleOfBusinessCombinationReverseMergerTable" xlink:label="loc_dare_ScheduleOfBusinessCombinationReverseMergerTable_86336E94DDC6C54F551B78071B32E092" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_5D0E7B7B0D915F63682678071B324D6E" xlink:to="loc_dare_ScheduleOfBusinessCombinationReverseMergerTable_86336E94DDC6C54F551B78071B32E092" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_2D5D82A228207C7BEE9578071B332A20" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_ScheduleOfBusinessCombinationReverseMergerTable_86336E94DDC6C54F551B78071B32E092" xlink:to="loc_dei_LegalEntityAxis_2D5D82A228207C7BEE9578071B332A20" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_0D613F3323383CF311EA78071B3355C4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2D5D82A228207C7BEE9578071B332A20" xlink:to="loc_dei_EntityDomain_0D613F3323383CF311EA78071B3355C4" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_PrivateDareMember" xlink:label="loc_dare_PrivateDareMember_51385BB4DC243FD1FD5D78071B33789C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_0D613F3323383CF311EA78071B3355C4" xlink:to="loc_dare_PrivateDareMember_51385BB4DC243FD1FD5D78071B33789C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_31D0CB3D18C15FFF496478071B349120" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_ScheduleOfBusinessCombinationReverseMergerTable_86336E94DDC6C54F551B78071B32E092" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_31D0CB3D18C15FFF496478071B349120" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_B69EE32EB395B172742778071B3409FD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_31D0CB3D18C15FFF496478071B349120" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_B69EE32EB395B172742778071B3409FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5EFCDD3DD570538B187D78071B34F4B7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_B69EE32EB395B172742778071B3409FD" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5EFCDD3DD570538B187D78071B34F4B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_94AE358BA8FA391976FA78071B35F281" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_ScheduleOfBusinessCombinationReverseMergerTable_86336E94DDC6C54F551B78071B32E092" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_94AE358BA8FA391976FA78071B35F281" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50AA83230792B766CB6E78071B35BD04" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_94AE358BA8FA391976FA78071B35F281" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50AA83230792B766CB6E78071B35BD04" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_PearTreePharmaceuticalsIncMember" xlink:label="loc_dare_PearTreePharmaceuticalsIncMember_E43C6D1B2DEFDA4BD42678071B3508D7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50AA83230792B766CB6E78071B35BD04" xlink:to="loc_dare_PearTreePharmaceuticalsIncMember_E43C6D1B2DEFDA4BD42678071B3508D7" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_BusinessCombinationReverseMergerLineItems" xlink:label="loc_dare_BusinessCombinationReverseMergerLineItems_0E36739B3FAEBF7A5BA878071B35FCEA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_ScheduleOfBusinessCombinationReverseMergerTable_86336E94DDC6C54F551B78071B32E092" xlink:to="loc_dare_BusinessCombinationReverseMergerLineItems_0E36739B3FAEBF7A5BA878071B35FCEA" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_91314AC76F46EC58227C78071B367392" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_0E36739B3FAEBF7A5BA878071B35FCEA" xlink:to="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_91314AC76F46EC58227C78071B367392" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_BusinessCombinationReverseMergerUnamortizedFairValueOfStockOptions" xlink:label="loc_dare_BusinessCombinationReverseMergerUnamortizedFairValueOfStockOptions_3EEE1C3BE117D05B931C78071B363A56" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_0E36739B3FAEBF7A5BA878071B35FCEA" xlink:to="loc_dare_BusinessCombinationReverseMergerUnamortizedFairValueOfStockOptions_3EEE1C3BE117D05B931C78071B363A56" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_16AE243469526DBBAC9278071B361CA2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_0E36739B3FAEBF7A5BA878071B35FCEA" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_16AE243469526DBBAC9278071B361CA2" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_BusinessCombinationReverseMergerStockPurchaseTransactionCost" xlink:label="loc_dare_BusinessCombinationReverseMergerStockPurchaseTransactionCost_17C634478ABBE254F63F78071B36F77D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_0E36739B3FAEBF7A5BA878071B35FCEA" xlink:to="loc_dare_BusinessCombinationReverseMergerStockPurchaseTransactionCost_17C634478ABBE254F63F78071B36F77D" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_PotentialCashPaymentsToAcquireBusiness" xlink:label="loc_dare_PotentialCashPaymentsToAcquireBusiness_968E61EDF481090A4BA678071B379F45" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_0E36739B3FAEBF7A5BA878071B35FCEA" xlink:to="loc_dare_PotentialCashPaymentsToAcquireBusiness_968E61EDF481090A4BA678071B379F45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_558AF06E9A39988580D378071B3637DA" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_0E36739B3FAEBF7A5BA878071B35FCEA" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_558AF06E9A39988580D378071B3637DA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/CommitmentsAndContingencies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_E2D11AC3FA485A1CA8CED1CFC621C30A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_EE0D071AB3325E62B047371FB6DA0136" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_E2D11AC3FA485A1CA8CED1CFC621C30A" xlink:to="loc_us-gaap_CommitmentsDisclosureTextBlock_EE0D071AB3325E62B047371FB6DA0136" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_B893FF5D443867559F25720E1C2554D9" xlink:type="locator" />
    <link:loc xlink:href="dare-20190630.xsd#dare_CommitmentsAndContingenciesTable" xlink:label="loc_dare_CommitmentsAndContingenciesTable_C53AE5C20B07D16974A6720E1C25B34B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_B893FF5D443867559F25720E1C2554D9" xlink:to="loc_dare_CommitmentsAndContingenciesTable_C53AE5C20B07D16974A6720E1C25B34B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_D25F1F1D0BF2DC03B48B720E1C25ED65" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_C53AE5C20B07D16974A6720E1C25B34B" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_D25F1F1D0BF2DC03B48B720E1C25ED65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProjectMember" xlink:label="loc_us-gaap_ProjectMember_722FBC585D3024F5315F720E1C262189" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_D25F1F1D0BF2DC03B48B720E1C25ED65" xlink:to="loc_us-gaap_ProjectMember_722FBC585D3024F5315F720E1C262189" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_UponAchievementOfSpecifiedDevelopmentAndRegulatoryMilestonesMember" xlink:label="loc_dare_UponAchievementOfSpecifiedDevelopmentAndRegulatoryMilestonesMember_A72C35F79E69282B6837720E1C261189" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_722FBC585D3024F5315F720E1C262189" xlink:to="loc_dare_UponAchievementOfSpecifiedDevelopmentAndRegulatoryMilestonesMember_A72C35F79E69282B6837720E1C261189" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_UponReachingCertainWorldwideNetSalesMilestonesMember" xlink:label="loc_dare_UponReachingCertainWorldwideNetSalesMilestonesMember_84B1512373E5946AF257720E1C261AB6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_722FBC585D3024F5315F720E1C262189" xlink:to="loc_dare_UponReachingCertainWorldwideNetSalesMilestonesMember_84B1512373E5946AF257720E1C261AB6" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_FutureMilestonePaymentsBasedOnProductDevelopmentMember" xlink:label="loc_dare_FutureMilestonePaymentsBasedOnProductDevelopmentMember_8DD6B9085A618E8DB92E7215FDBADEC3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_722FBC585D3024F5315F720E1C262189" xlink:to="loc_dare_FutureMilestonePaymentsBasedOnProductDevelopmentMember_8DD6B9085A618E8DB92E7215FDBADEC3" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_FutureMilestonePaymentsBasedOnCommercializationMember" xlink:label="loc_dare_FutureMilestonePaymentsBasedOnCommercializationMember_667B5EE6168008B41A1F721678E97197" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_722FBC585D3024F5315F720E1C262189" xlink:to="loc_dare_FutureMilestonePaymentsBasedOnCommercializationMember_667B5EE6168008B41A1F721678E97197" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_E44AAEFB6E0F915DCF61720E1C26F1F2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_C53AE5C20B07D16974A6720E1C25B34B" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_E44AAEFB6E0F915DCF61720E1C26F1F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_A10CBF90CB549683B63A720E1C272750" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_E44AAEFB6E0F915DCF61720E1C26F1F2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_A10CBF90CB549683B63A720E1C272750" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_UponAchievingCertainCommercialMilestonesMember" xlink:label="loc_dare_UponAchievingCertainCommercialMilestonesMember_EB5B5D7312F21BC78993720E1C27AA3F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_A10CBF90CB549683B63A720E1C272750" xlink:to="loc_dare_UponAchievingCertainCommercialMilestonesMember_EB5B5D7312F21BC78993720E1C27AA3F" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_UponSigningOfDevelopmentAndOptionAgreementMember" xlink:label="loc_dare_UponSigningOfDevelopmentAndOptionAgreementMember_46FAF28F5A9E7FA57356720E1C275A40" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_A10CBF90CB549683B63A720E1C272750" xlink:to="loc_dare_UponSigningOfDevelopmentAndOptionAgreementMember_46FAF28F5A9E7FA57356720E1C275A40" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_UponCompletionOfFiftyPercentDevelopmentNotLaterThanSixMonthsMember" xlink:label="loc_dare_UponCompletionOfFiftyPercentDevelopmentNotLaterThanSixMonthsMember_D5F6C1747ACD5AB86DCB720E1C28D305" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_A10CBF90CB549683B63A720E1C272750" xlink:to="loc_dare_UponCompletionOfFiftyPercentDevelopmentNotLaterThanSixMonthsMember_D5F6C1747ACD5AB86DCB720E1C28D305" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_UponAchievingCertainClinicalAndRegulatoryDevelopmentMilestonesMember" xlink:label="loc_dare_UponAchievingCertainClinicalAndRegulatoryDevelopmentMilestonesMember_BF1822E529A6428D8621720E1C286B81" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_A10CBF90CB549683B63A720E1C272750" xlink:to="loc_dare_UponAchievingCertainClinicalAndRegulatoryDevelopmentMilestonesMember_BF1822E529A6428D8621720E1C286B81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_33BFA660C11DBCD8B660720E1C285693" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_C53AE5C20B07D16974A6720E1C25B34B" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_33BFA660C11DBCD8B660720E1C285693" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_E0A0BA01A6D07415477F720E1C2811BA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_33BFA660C11DBCD8B660720E1C285693" xlink:to="loc_us-gaap_RelatedPartyDomain_E0A0BA01A6D07415477F720E1C2811BA" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_StrategicScienceAndTechnologiesDLimitedLiabilityCompanyAndStrategicScienceTechnologiesLimitedLiabilityCompanyMember" xlink:label="loc_dare_StrategicScienceAndTechnologiesDLimitedLiabilityCompanyAndStrategicScienceTechnologiesLimitedLiabilityCompanyMember_A9153B2B0DEA56385509720E1C28E6BF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_E0A0BA01A6D07415477F720E1C2811BA" xlink:to="loc_dare_StrategicScienceAndTechnologiesDLimitedLiabilityCompanyAndStrategicScienceTechnologiesLimitedLiabilityCompanyMember_A9153B2B0DEA56385509720E1C28E6BF" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_OrbisMember" xlink:label="loc_dare_OrbisMember_6C858185A7CD5A0A7A7F720E1C2949EB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_E0A0BA01A6D07415477F720E1C2811BA" xlink:to="loc_dare_OrbisMember_6C858185A7CD5A0A7A7F720E1C2949EB" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_MilanaPharmMember" xlink:label="loc_dare_MilanaPharmMember_F8B6EBFED2E14641207F720E1C296A97" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_E0A0BA01A6D07415477F720E1C2811BA" xlink:to="loc_dare_MilanaPharmMember_F8B6EBFED2E14641207F720E1C296A97" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_HammockPharmaceuticalsInc.Member" xlink:label="loc_dare_HammockPharmaceuticalsInc.Member_FA0DF05BBC852E4D6732720E1C2905C4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_E0A0BA01A6D07415477F720E1C2811BA" xlink:to="loc_dare_HammockPharmaceuticalsInc.Member_FA0DF05BBC852E4D6732720E1C2905C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_314BFD22D11D6EFA7B4A720E1C294E06" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_C53AE5C20B07D16974A6720E1C25B34B" xlink:to="loc_us-gaap_TypeOfArrangementAxis_314BFD22D11D6EFA7B4A720E1C294E06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_03B7A05B0221B1582680720E1C2AF8C3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_314BFD22D11D6EFA7B4A720E1C294E06" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_03B7A05B0221B1582680720E1C2AF8C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaap_LicensingAgreementsMember_CF68F6EDABAE306ED9C6720E1C2A8150" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_03B7A05B0221B1582680720E1C2AF8C3" xlink:to="loc_us-gaap_LicensingAgreementsMember_CF68F6EDABAE306ED9C6720E1C2A8150" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_AssignmentAgreementMember" xlink:label="loc_dare_AssignmentAgreementMember_340589595C152C4A9797720E1C2A8B5E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_03B7A05B0221B1582680720E1C2AF8C3" xlink:to="loc_dare_AssignmentAgreementMember_340589595C152C4A9797720E1C2A8B5E" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_LicenseAndCollaborationAgreementMember" xlink:label="loc_dare_LicenseAndCollaborationAgreementMember_57C63C1FD973C896CFC9720E1C2A798D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_03B7A05B0221B1582680720E1C2AF8C3" xlink:to="loc_dare_LicenseAndCollaborationAgreementMember_57C63C1FD973C896CFC9720E1C2A798D" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_DevelopmentAndOptionAgreementMember" xlink:label="loc_dare_DevelopmentAndOptionAgreementMember_53B16A4503175560998F720E1C2B1BEC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_03B7A05B0221B1582680720E1C2AF8C3" xlink:to="loc_dare_DevelopmentAndOptionAgreementMember_53B16A4503175560998F720E1C2B1BEC" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_JuniperPharmaceuticalsInc.Member" xlink:label="loc_dare_JuniperPharmaceuticalsInc.Member_C669DECFBE7E4C9B1722720E1C2B059B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_03B7A05B0221B1582680720E1C2AF8C3" xlink:to="loc_dare_JuniperPharmaceuticalsInc.Member_C669DECFBE7E4C9B1722720E1C2B059B" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_JuniperPharmaceuticalsMember" xlink:label="loc_dare_JuniperPharmaceuticalsMember_B5E44CE6DC6E200959C4720E1C2B9189" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_03B7A05B0221B1582680720E1C2AF8C3" xlink:to="loc_dare_JuniperPharmaceuticalsMember_B5E44CE6DC6E200959C4720E1C2B9189" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_17C97A0B2D467DFC5029720E1C2C00FE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_C53AE5C20B07D16974A6720E1C25B34B" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_17C97A0B2D467DFC5029720E1C2C00FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_F1A27082EB7FD4E36874720E1C2C52DB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_17C97A0B2D467DFC5029720E1C2C00FE" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_F1A27082EB7FD4E36874720E1C2C52DB" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_ADVATecAgreementMember" xlink:label="loc_dare_ADVATecAgreementMember_6B4FAF095DBE9F8EA93A720E1C2C4235" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_F1A27082EB7FD4E36874720E1C2C52DB" xlink:to="loc_dare_ADVATecAgreementMember_6B4FAF095DBE9F8EA93A720E1C2C4235" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_ClinicalAndRegulatoryMilestonesMember" xlink:label="loc_dare_ClinicalAndRegulatoryMilestonesMember_E0F632337C5682F377BE720E1C2C7442" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_F1A27082EB7FD4E36874720E1C2C52DB" xlink:to="loc_dare_ClinicalAndRegulatoryMilestonesMember_E0F632337C5682F377BE720E1C2C7442" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_SalesMilestonesMember" xlink:label="loc_dare_SalesMilestonesMember_7E93522D4E5A566BA157720E1C2DBBE1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_F1A27082EB7FD4E36874720E1C2C52DB" xlink:to="loc_dare_SalesMilestonesMember_7E93522D4E5A566BA157720E1C2DBBE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_6DB419DE9465D9775C20720E1C2DBF4D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_C53AE5C20B07D16974A6720E1C25B34B" xlink:to="loc_srt_RangeAxis_6DB419DE9465D9775C20720E1C2DBF4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_108BCB3D27EA514E41BB720E1C2D6661" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6DB419DE9465D9775C20720E1C2DBF4D" xlink:to="loc_srt_RangeMember_108BCB3D27EA514E41BB720E1C2D6661" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_F8C594F496E0AD8867C1720E1C2E1FA0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_108BCB3D27EA514E41BB720E1C2D6661" xlink:to="loc_srt_MinimumMember_F8C594F496E0AD8867C1720E1C2E1FA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_A47D8BB2B75CA86BDFE4720E1C2F07E1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_108BCB3D27EA514E41BB720E1C2D6661" xlink:to="loc_srt_MaximumMember_A47D8BB2B75CA86BDFE4720E1C2F07E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_CC91522DFFB65E8551BE720E1C30F63B" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_C53AE5C20B07D16974A6720E1C25B34B" xlink:to="loc_srt_ProductOrServiceAxis_CC91522DFFB65E8551BE720E1C30F63B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_8871E537A9ACC680495A720E1C30BCC3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_CC91522DFFB65E8551BE720E1C30F63B" xlink:to="loc_srt_ProductsAndServicesDomain_8871E537A9ACC680495A720E1C30BCC3" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_OvapreneMember" xlink:label="loc_dare_OvapreneMember_972EAC232AF68E34625B720E1C318C87" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8871E537A9ACC680495A720E1C30BCC3" xlink:to="loc_dare_OvapreneMember_972EAC232AF68E34625B720E1C318C87" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_CommitmentsAndContingenciesLineItems" xlink:label="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_C53AE5C20B07D16974A6720E1C25B34B" xlink:to="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_NumberOfPatentsIssued" xlink:label="loc_dare_NumberOfPatentsIssued_DC3759BF5CBAF4FB05A8720E1C32EFDC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_NumberOfPatentsIssued_DC3759BF5CBAF4FB05A8720E1C32EFDC" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_NumberOfPendingPatents" xlink:label="loc_dare_NumberOfPendingPatents_091BCD5571D073B6E088720E1C32F0C1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_NumberOfPendingPatents_091BCD5571D073B6E088720E1C32F0C1" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_NumberOfPatentsGranted" xlink:label="loc_dare_NumberOfPatentsGranted_C09ED940D44D9DFCACAE720E1C328B60" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_NumberOfPatentsGranted_C09ED940D44D9DFCACAE720E1C328B60" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_NumberOfPatentApplications" xlink:label="loc_dare_NumberOfPatentApplications_AE419E1CED16AD89560B720E1C339342" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_NumberOfPatentApplications_AE419E1CED16AD89560B720E1C339342" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligation" xlink:label="loc_us-gaap_ContractualObligation_12566402C85BBDBBF934720E1C33B332" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_us-gaap_ContractualObligation_12566402C85BBDBBF934720E1C33B332" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_AgreementTerminationPeriodOnFailingToCommercializeInCertainDesignatedCountries" xlink:label="loc_dare_AgreementTerminationPeriodOnFailingToCommercializeInCertainDesignatedCountries_39239BFC16A9EA2F225F720E1C33F8D1" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_AgreementTerminationPeriodOnFailingToCommercializeInCertainDesignatedCountries_39239BFC16A9EA2F225F720E1C33F8D1" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_NumberOfDesignatedCountries" xlink:label="loc_dare_NumberOfDesignatedCountries_6F550C419C7157CAA2A1720E1C339D1B" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_NumberOfDesignatedCountries_6F550C419C7157CAA2A1720E1C339D1B" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_PercentageOfRoyaltyRate" xlink:label="loc_dare_PercentageOfRoyaltyRate_53BE2ACF30C4616D0082720E1C34ED4A" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_PercentageOfRoyaltyRate_53BE2ACF30C4616D0082720E1C34ED4A" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_LicenseAgreementTerminationPeriodDueToPerformanceFailure" xlink:label="loc_dare_LicenseAgreementTerminationPeriodDueToPerformanceFailure_921A9CEE5A93503856E3720E1C342EBC" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_LicenseAgreementTerminationPeriodDueToPerformanceFailure_921A9CEE5A93503856E3720E1C342EBC" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_AgreementTerminationOnFailingToEnrollPatientWithinMonthsOfProductionAndRelease" xlink:label="loc_dare_AgreementTerminationOnFailingToEnrollPatientWithinMonthsOfProductionAndRelease_A61483944156CEFC28B0720E1C34C7EF" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_AgreementTerminationOnFailingToEnrollPatientWithinMonthsOfProductionAndRelease_A61483944156CEFC28B0720E1C34C7EF" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_PercentageOfRightsToInventionsByEmployeesUnderLicenseAgreement" xlink:label="loc_dare_PercentageOfRightsToInventionsByEmployeesUnderLicenseAgreement_A2215BC3F6476F40CA36720E1C34514D" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_PercentageOfRightsToInventionsByEmployeesUnderLicenseAgreement_A2215BC3F6476F40CA36720E1C34514D" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_MilestonePaymentsContingentAmount" xlink:label="loc_dare_MilestonePaymentsContingentAmount_016410222CF3C4AC264A720E1C359D10" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_MilestonePaymentsContingentAmount_016410222CF3C4AC264A720E1C359D10" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_SecuredInvestmentRequiredForLicenseAgreement" xlink:label="loc_dare_SecuredInvestmentRequiredForLicenseAgreement_21821E41A96414ED1831720E1C3566D9" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_SecuredInvestmentRequiredForLicenseAgreement_21821E41A96414ED1831720E1C3566D9" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_LicenseAgreementExpirationPeriod" xlink:label="loc_dare_LicenseAgreementExpirationPeriod_32F365D4A7C0277864A4720E1C355CCA" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_LicenseAgreementExpirationPeriod_32F365D4A7C0277864A4720E1C355CCA" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_LicenseAgreementTerminationPeriodPriorToReceiptOfApproval" xlink:label="loc_dare_LicenseAgreementTerminationPeriodPriorToReceiptOfApproval_839B01738675A05CB4C6720E1C3520C3" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_LicenseAgreementTerminationPeriodPriorToReceiptOfApproval_839B01738675A05CB4C6720E1C3520C3" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_LicenseAgreementTerminationPeriodAfterReceiptOfApproval" xlink:label="loc_dare_LicenseAgreementTerminationPeriodAfterReceiptOfApproval_0F186928003DEFE63BD0720E1C3515F3" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_LicenseAgreementTerminationPeriodAfterReceiptOfApproval_0F186928003DEFE63BD0720E1C3515F3" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_LicenseAgreementTerminationPeriodForApplicableLicenseProductsOfApplicableCountries" xlink:label="loc_dare_LicenseAgreementTerminationPeriodForApplicableLicenseProductsOfApplicableCountries_FB09EFBEF29880AC234A720E1C361E22" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_LicenseAgreementTerminationPeriodForApplicableLicenseProductsOfApplicableCountries_FB09EFBEF29880AC234A720E1C361E22" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_NoticePeriodForTerminationOfAgreementForBothParties" xlink:label="loc_dare_NoticePeriodForTerminationOfAgreementForBothParties_FCA851E45049B2E03A7F720E1C36A3AC" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_NoticePeriodForTerminationOfAgreementForBothParties_FCA851E45049B2E03A7F720E1C36A3AC" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_ResearchAndDevelopmentMilestonePayment" xlink:label="loc_dare_ResearchAndDevelopmentMilestonePayment_FFB065DC5477EF1F92B3720E1C361D21" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_ResearchAndDevelopmentMilestonePayment_FFB065DC5477EF1F92B3720E1C361D21" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_CommencementPeriodForStageTwoUponAchievementOfStageOne" xlink:label="loc_dare_CommencementPeriodForStageTwoUponAchievementOfStageOne_6BF65CAE4EB51023B960720E1C368B0C" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_CommencementPeriodForStageTwoUponAchievementOfStageOne_6BF65CAE4EB51023B960720E1C368B0C" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_UpfrontLicenseFeePaid" xlink:label="loc_dare_UpfrontLicenseFeePaid_B24534E7ABB0A7E59847720E1C37FB2D" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_UpfrontLicenseFeePaid_B24534E7ABB0A7E59847720E1C37FB2D" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_PotentialAnnualLicenseMaintenanceFeePaymentsInYearOne" xlink:label="loc_dare_PotentialAnnualLicenseMaintenanceFeePaymentsInYearOne_D9BE6B1057B91F64F1BD720E1C3743AD" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_PotentialAnnualLicenseMaintenanceFeePaymentsInYearOne_D9BE6B1057B91F64F1BD720E1C3743AD" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_PotentialAnnualLicenseMaintenanceFeePaymentsThereafter" xlink:label="loc_dare_PotentialAnnualLicenseMaintenanceFeePaymentsThereafter_D0E5C5B61A6D20252032720E1C376C29" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_PotentialAnnualLicenseMaintenanceFeePaymentsThereafter_D0E5C5B61A6D20252032720E1C376C29" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_MaximumPotentialMilestonePayments" xlink:label="loc_dare_MaximumPotentialMilestonePayments_530439A9C6E9058269CF720E1C376DAF" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_MaximumPotentialMilestonePayments_530439A9C6E9058269CF720E1C376DAF" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_LicenseAgreementPeriodOfContinuationFromDateOfFirstCommercialSaleOfProductOrProcess" xlink:label="loc_dare_LicenseAgreementPeriodOfContinuationFromDateOfFirstCommercialSaleOfProductOrProcess_65139A6CCD39FE9D42F0720E1C372815" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_LicenseAgreementPeriodOfContinuationFromDateOfFirstCommercialSaleOfProductOrProcess_65139A6CCD39FE9D42F0720E1C372815" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_LicenseAgreementNoticePeriodOfTerminationForBreachOfPaymentObligation" xlink:label="loc_dare_LicenseAgreementNoticePeriodOfTerminationForBreachOfPaymentObligation_224C8E87C7DAB371E449720E1C38A77B" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_LicenseAgreementNoticePeriodOfTerminationForBreachOfPaymentObligation_224C8E87C7DAB371E449720E1C38A77B" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_PeriodOfDismissalOfBankruptcyPetition" xlink:label="loc_dare_PeriodOfDismissalOfBankruptcyPetition_BC42B900241BBC0C011C720E1C388CC9" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_PeriodOfDismissalOfBankruptcyPetition_BC42B900241BBC0C011C720E1C388CC9" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_LicenseAgreementNoticePeriodOfTerminationForBreachOfOtherObligation" xlink:label="loc_dare_LicenseAgreementNoticePeriodOfTerminationForBreachOfOtherObligation_866B4CBEDF3BE825A323720E1C387990" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_LicenseAgreementNoticePeriodOfTerminationForBreachOfOtherObligation_866B4CBEDF3BE825A323720E1C387990" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_LicenseAgreementNoticePeriodOfTermination" xlink:label="loc_dare_LicenseAgreementNoticePeriodOfTermination_2C4FBB033C3F176251B4720E1C38B453" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_LicenseAgreementNoticePeriodOfTermination_2C4FBB033C3F176251B4720E1C38B453" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_LicenseFee" xlink:label="loc_dare_LicenseFee_A171B0D4889E8B0951BD720E1C392A40" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_LicenseFee_A171B0D4889E8B0951BD720E1C392A40" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_LicenseFeeToBePaidUponContingency" xlink:label="loc_dare_LicenseFeeToBePaidUponContingency_B72D6C752DFE7374A0C1720E1C39F57D" xlink:type="locator" />
    <link:presentationArc order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_LicenseFeeToBePaidUponContingency_B72D6C752DFE7374A0C1720E1C39F57D" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_ProceedsRaisedFromEquityFinancing" xlink:label="loc_dare_ProceedsRaisedFromEquityFinancing_80637EDC7C0C9433F246720E1C392191" xlink:type="locator" />
    <link:presentationArc order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_9D561BB3FACCE0F8003B720E1C31C5FC" xlink:to="loc_dare_ProceedsRaisedFromEquityFinancing_80637EDC7C0C9433F246720E1C392191" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2085522664A62DCCA89A6D22BA93EABF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_6E17FAD2BC86770A4A2A6D22BA932AD2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2085522664A62DCCA89A6D22BA93EABF" xlink:to="loc_us-gaap_AssetsAbstract_6E17FAD2BC86770A4A2A6D22BA932AD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_A3BD2B7392438E2F94B36D22BA933FE6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6E17FAD2BC86770A4A2A6D22BA932AD2" xlink:to="loc_us-gaap_AssetsCurrentAbstract_A3BD2B7392438E2F94B36D22BA933FE6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_13E0112DEA6CD878F6806D22BA933835" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_A3BD2B7392438E2F94B36D22BA933FE6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_13E0112DEA6CD878F6806D22BA933835" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_ACA77A1BBCC7FAF845106D22BA9330DE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_A3BD2B7392438E2F94B36D22BA933FE6" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_ACA77A1BBCC7FAF845106D22BA9330DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_686E43C0C9032871E1666D22BA93E687" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_A3BD2B7392438E2F94B36D22BA933FE6" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_686E43C0C9032871E1666D22BA93E687" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_1A0AC4428FBF92B7DEF86D22BA9357EC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_A3BD2B7392438E2F94B36D22BA933FE6" xlink:to="loc_us-gaap_AssetsCurrent_1A0AC4428FBF92B7DEF86D22BA9357EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_879C785C0BA92F60F32B6D22BA937783" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6E17FAD2BC86770A4A2A6D22BA932AD2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_879C785C0BA92F60F32B6D22BA937783" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_D45DFB766DECCD3E49126D22BA93A7D3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6E17FAD2BC86770A4A2A6D22BA932AD2" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_D45DFB766DECCD3E49126D22BA93A7D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_00B4019C7331E002C2FE6D22BAA3A3CE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6E17FAD2BC86770A4A2A6D22BA932AD2" xlink:to="loc_us-gaap_Assets_00B4019C7331E002C2FE6D22BAA3A3CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2EBDB0A497D24D0DA3406D22BAA375DB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2085522664A62DCCA89A6D22BA93EABF" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2EBDB0A497D24D0DA3406D22BAA375DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_DA10F9684FAFDE2214476D22BAA3091C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2EBDB0A497D24D0DA3406D22BAA375DB" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_DA10F9684FAFDE2214476D22BAA3091C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_A3714DA41BC27E3C25A16D22BAA348B1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_DA10F9684FAFDE2214476D22BAA3091C" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_A3714DA41BC27E3C25A16D22BAA348B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4A87FA7AAB34F7548DE26D22BAA34977" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_DA10F9684FAFDE2214476D22BAA3091C" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4A87FA7AAB34F7548DE26D22BAA34977" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_97F4F879AB059FF9FDC26D22BAA36C39" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_DA10F9684FAFDE2214476D22BAA3091C" xlink:to="loc_us-gaap_LiabilitiesCurrent_97F4F879AB059FF9FDC26D22BAA36C39" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_6C54E53169E7D4C2F6786D22BAA3BF0F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2EBDB0A497D24D0DA3406D22BAA375DB" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_6C54E53169E7D4C2F6786D22BAA3BF0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_F2034829B5396D6E934A6D22BAA3CC6E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2EBDB0A497D24D0DA3406D22BAA375DB" xlink:to="loc_us-gaap_Liabilities_F2034829B5396D6E934A6D22BAA3CC6E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_5CE4EEE5F306A0E9E3C66D22BAA3D841" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2EBDB0A497D24D0DA3406D22BAA375DB" xlink:to="loc_us-gaap_CommitmentsAndContingencies_5CE4EEE5F306A0E9E3C66D22BAA3D841" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_571C2B8C5329D30343326D22BAA310E5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2EBDB0A497D24D0DA3406D22BAA375DB" xlink:to="loc_us-gaap_StockholdersEquityAbstract_571C2B8C5329D30343326D22BAA310E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_924DE14A8C3359FDA4196D22BAA384C4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_571C2B8C5329D30343326D22BAA310E5" xlink:to="loc_us-gaap_PreferredStockValue_924DE14A8C3359FDA4196D22BAA384C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_49367BEC90C65C60C9E86D22BAA3EDA2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_571C2B8C5329D30343326D22BAA310E5" xlink:to="loc_us-gaap_CommonStockValue_49367BEC90C65C60C9E86D22BAA3EDA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_F37D532F138E083470BE6D22BAA3A7D0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_571C2B8C5329D30343326D22BAA310E5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_F37D532F138E083470BE6D22BAA3A7D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7873F9EF5D1DA4606B966D22BAA39747" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_571C2B8C5329D30343326D22BAA310E5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7873F9EF5D1DA4606B966D22BAA39747" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_31C635E80DFFF1CBCC0E6D22BAA38E60" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_571C2B8C5329D30343326D22BAA310E5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_31C635E80DFFF1CBCC0E6D22BAA38E60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_B187C728BE30E56855CD6D22BAA3E156" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_571C2B8C5329D30343326D22BAA310E5" xlink:to="loc_us-gaap_StockholdersEquity_B187C728BE30E56855CD6D22BAA3E156" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_353611D57C1197C8F34C6D22BAA33B8F" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2EBDB0A497D24D0DA3406D22BAA375DB" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_353611D57C1197C8F34C6D22BAA33B8F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_CA79CFD08A5C518794D8176DA72C0B4D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_B885B9A8FB7C5B6291545489DB7952F0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_CA79CFD08A5C518794D8176DA72C0B4D" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_B885B9A8FB7C5B6291545489DB7952F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1F9AD6BE0BCE5D39AE1926043E22F56F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_CA79CFD08A5C518794D8176DA72C0B4D" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1F9AD6BE0BCE5D39AE1926043E22F56F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_6A151FF0BCD6537EB59523EB4EDCAD13" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_CA79CFD08A5C518794D8176DA72C0B4D" xlink:to="loc_us-gaap_PreferredStockSharesIssued_6A151FF0BCD6537EB59523EB4EDCAD13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_B348AC900BBD5E9A970356B181784E3F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_CA79CFD08A5C518794D8176DA72C0B4D" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_B348AC900BBD5E9A970356B181784E3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_08299D1A3C7956C4A2BEDA557E28B274" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_CA79CFD08A5C518794D8176DA72C0B4D" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_08299D1A3C7956C4A2BEDA557E28B274" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_37C00890D6FD56DDB1DE1EE0F276A769" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_CA79CFD08A5C518794D8176DA72C0B4D" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_37C00890D6FD56DDB1DE1EE0F276A769" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_E9ADA20987D05A6EAE9628438D86EA55" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_CA79CFD08A5C518794D8176DA72C0B4D" xlink:to="loc_us-gaap_CommonStockSharesIssued_E9ADA20987D05A6EAE9628438D86EA55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1D6246BCBF67595DB12CDBBDE7F9DF4E" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_CA79CFD08A5C518794D8176DA72C0B4D" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1D6246BCBF67595DB12CDBBDE7F9DF4E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_C0E3988C3FB3112DCC6C865C0EB2EC53" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16972476295511CD7A75865C0EB3E259" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_C0E3988C3FB3112DCC6C865C0EB2EC53" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16972476295511CD7A75865C0EB3E259" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_620C0BC18DA801B7469C865C0EB34A89" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16972476295511CD7A75865C0EB3E259" xlink:to="loc_us-gaap_ProfitLoss_620C0BC18DA801B7469C865C0EB34A89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D37B5AD5040C0F2BD86F865C0EB326A6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16972476295511CD7A75865C0EB3E259" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D37B5AD5040C0F2BD86F865C0EB326A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_A364D76AC133B044A03E865C0EB3413C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D37B5AD5040C0F2BD86F865C0EB326A6" xlink:to="loc_us-gaap_Depreciation_A364D76AC133B044A03E865C0EB3413C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_066B05341720AF00368E865C0EB42790" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D37B5AD5040C0F2BD86F865C0EB326A6" xlink:to="loc_us-gaap_ShareBasedCompensation_066B05341720AF00368E865C0EB42790" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_NonCashLeaseExpense" xlink:label="loc_dare_NonCashLeaseExpense_2CD7AADB31880E3037E4865C0EB481E5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D37B5AD5040C0F2BD86F865C0EB326A6" xlink:to="loc_dare_NonCashLeaseExpense_2CD7AADB31880E3037E4865C0EB481E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_755130D369778C742CC9865C0EB5FBC1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D37B5AD5040C0F2BD86F865C0EB326A6" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_755130D369778C742CC9865C0EB5FBC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_10A06321A3CECCF04EBF865C0EB5FC18" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D37B5AD5040C0F2BD86F865C0EB326A6" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_10A06321A3CECCF04EBF865C0EB5FC18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_769A39BCCB12D2B98427865C0EB6D9E9" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D37B5AD5040C0F2BD86F865C0EB326A6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_769A39BCCB12D2B98427865C0EB6D9E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_C03F2D63848BF65558B9865C0EB6D00F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_769A39BCCB12D2B98427865C0EB6D9E9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_C03F2D63848BF65558B9865C0EB6D00F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_58CA6CE0CA381CDCC8FF865C0EB6C76E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_769A39BCCB12D2B98427865C0EB6D9E9" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_58CA6CE0CA381CDCC8FF865C0EB6C76E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_FB6A38E9742573596440865C0EB6FB64" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_769A39BCCB12D2B98427865C0EB6D9E9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_FB6A38E9742573596440865C0EB6FB64" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_IncreaseDecreaseInOtherNonCurrentAssetsAndDeferredCharges" xlink:label="loc_dare_IncreaseDecreaseInOtherNonCurrentAssetsAndDeferredCharges_CA0D50C67A7FAA55812D865C0EB7D5B5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_769A39BCCB12D2B98427865C0EB6D9E9" xlink:to="loc_dare_IncreaseDecreaseInOtherNonCurrentAssetsAndDeferredCharges_CA0D50C67A7FAA55812D865C0EB7D5B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9FE3805882EC9BA94673865C0EB7372B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_769A39BCCB12D2B98427865C0EB6D9E9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9FE3805882EC9BA94673865C0EB7372B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_E84AB8DE84DB0F7875E3865C0EB788EB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_769A39BCCB12D2B98427865C0EB6D9E9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_E84AB8DE84DB0F7875E3865C0EB788EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_FA15B10455EECDC31AD1865C0EB747AF" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_769A39BCCB12D2B98427865C0EB6D9E9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_FA15B10455EECDC31AD1865C0EB747AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8EAA7732079C86B534D1865C0EB8CAB8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16972476295511CD7A75865C0EB3E259" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8EAA7732079C86B534D1865C0EB8CAB8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_EF31235DDBF306CC6E92865C0EB8A1FF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_C0E3988C3FB3112DCC6C865C0EB2EC53" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_EF31235DDBF306CC6E92865C0EB8A1FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_876F124365D5C2842445865C0EB83AA8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_EF31235DDBF306CC6E92865C0EB8A1FF" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_876F124365D5C2842445865C0EB83AA8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_A71BA714FA255AECF143865C0EB95CA2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_EF31235DDBF306CC6E92865C0EB8A1FF" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_A71BA714FA255AECF143865C0EB95CA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_53FC9781EE88117692FF865C0EB9C36E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_EF31235DDBF306CC6E92865C0EB8A1FF" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_53FC9781EE88117692FF865C0EB9C36E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3851664C657ABFE32FFA865C0EB96BB1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_C0E3988C3FB3112DCC6C865C0EB2EC53" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3851664C657ABFE32FFA865C0EB96BB1" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_NetProceedsFromIssuanceOfCommonStockAndWarrants" xlink:label="loc_dare_NetProceedsFromIssuanceOfCommonStockAndWarrants_1D5D56E72D42D37B74AB865C0EB9BBEF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3851664C657ABFE32FFA865C0EB96BB1" xlink:to="loc_dare_NetProceedsFromIssuanceOfCommonStockAndWarrants_1D5D56E72D42D37B74AB865C0EB9BBEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_E502396634C97380F5A5865C0EBA4768" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3851664C657ABFE32FFA865C0EB96BB1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_E502396634C97380F5A5865C0EBA4768" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_6F23FE7432EB29FB1D65865C0EBA0326" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_C0E3988C3FB3112DCC6C865C0EB2EC53" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_6F23FE7432EB29FB1D65865C0EBA0326" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8DCD5C130DBBBAE88F52865C0EBA0354" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_C0E3988C3FB3112DCC6C865C0EB2EC53" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8DCD5C130DBBBAE88F52865C0EBA0354" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_639D75E9B23F8FDBC847865C0EBA67D2" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_C0E3988C3FB3112DCC6C865C0EB2EC53" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_639D75E9B23F8FDBC847865C0EBA67D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6E4A42D6C3DFA49D294B865C0EBB491A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_C0E3988C3FB3112DCC6C865C0EB2EC53" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6E4A42D6C3DFA49D294B865C0EBB491A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_37DFFB45CF61497CED0C865C0EBB4429" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_C0E3988C3FB3112DCC6C865C0EB2EC53" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_37DFFB45CF61497CED0C865C0EBB4429" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_A4625E645EE86A2872CB865C0EBB4CD9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_37DFFB45CF61497CED0C865C0EBB4429" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_A4625E645EE86A2872CB865C0EBB4CD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount" xlink:label="loc_us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_F2B6276AC516CC96708486AA97B642B3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_37DFFB45CF61497CED0C865C0EBB4429" xlink:to="loc_us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_F2B6276AC516CC96708486AA97B642B3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_FFAC18AD972FBB106C0D865C0ED00189" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_D848ECCCE25A8214DCB2865C0ED0F7C1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FFAC18AD972FBB106C0D865C0ED00189" xlink:to="loc_us-gaap_OperatingExpensesAbstract_D848ECCCE25A8214DCB2865C0ED0F7C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_629622F28590C0B5D6A2865C0ED0282C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_D848ECCCE25A8214DCB2865C0ED0F7C1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_629622F28590C0B5D6A2865C0ED0282C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_F1E45B9767D3A9D30683865C0ED16A74" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_D848ECCCE25A8214DCB2865C0ED0F7C1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_F1E45B9767D3A9D30683865C0ED16A74" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_LicenseFee" xlink:label="loc_dare_LicenseFee_1BB820BBA1EA3C425A26865C0ED1C108" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_D848ECCCE25A8214DCB2865C0ED0F7C1" xlink:to="loc_dare_LicenseFee_1BB820BBA1EA3C425A26865C0ED1C108" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2B100490F037264070B2865C0ED10374" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_D848ECCCE25A8214DCB2865C0ED0F7C1" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2B100490F037264070B2865C0ED10374" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_7D42BB96CEA2211160C6865C0ED11288" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_D848ECCCE25A8214DCB2865C0ED0F7C1" xlink:to="loc_us-gaap_OperatingExpenses_7D42BB96CEA2211160C6865C0ED11288" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_FC79F388FABE172B0836865C0ED11ADA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FFAC18AD972FBB106C0D865C0ED00189" xlink:to="loc_us-gaap_OperatingIncomeLoss_FC79F388FABE172B0836865C0ED11ADA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0C2351D81EEECAAA2416865C0ED1FDB4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FFAC18AD972FBB106C0D865C0ED00189" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0C2351D81EEECAAA2416865C0ED1FDB4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1111AE1DB781476263A6865C0ED2AC92" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FFAC18AD972FBB106C0D865C0ED00189" xlink:to="loc_us-gaap_NetIncomeLoss_1111AE1DB781476263A6865C0ED2AC92" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount" xlink:label="loc_us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_B4E75DA51F98FAE56AD486AB39E0E43A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FFAC18AD972FBB106C0D865C0ED00189" xlink:to="loc_us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_B4E75DA51F98FAE56AD486AB39E0E43A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9567D9B2A2711228827386914CA4F232" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FFAC18AD972FBB106C0D865C0ED00189" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9567D9B2A2711228827386914CA4F232" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_C7189E3550A83E89BC95865C0ED2CE99" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FFAC18AD972FBB106C0D865C0ED00189" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_C7189E3550A83E89BC95865C0ED2CE99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0C9641B9443865DFBAB8865C0ED23650" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FFAC18AD972FBB106C0D865C0ED00189" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_0C9641B9443865DFBAB8865C0ED23650" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_312DC196293A22866922865C0ED27BE8" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FFAC18AD972FBB106C0D865C0ED00189" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_312DC196293A22866922865C0ED27BE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_C81B30B32E57107C7338865C0ED3B632" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FFAC18AD972FBB106C0D865C0ED00189" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_C81B30B32E57107C7338865C0ED3B632" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_465BD153D06885C13AE7865C0ED35C9F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_C81B30B32E57107C7338865C0ED3B632" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_465BD153D06885C13AE7865C0ED35C9F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_005EC5BF97AA5459CAEE8B6FAE986326" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_A3F4F4A457B43093822A8B6FAE9B5F37" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_005EC5BF97AA5459CAEE8B6FAE986326" xlink:to="loc_us-gaap_StatementTable_A3F4F4A457B43093822A8B6FAE9B5F37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7E0C3649329E9CAEBA818B6FAE9CA943" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_A3F4F4A457B43093822A8B6FAE9B5F37" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7E0C3649329E9CAEBA818B6FAE9CA943" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_31871EDDC6D7CAF677998B6FAE9C288C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7E0C3649329E9CAEBA818B6FAE9CA943" xlink:to="loc_us-gaap_EquityComponentDomain_31871EDDC6D7CAF677998B6FAE9C288C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_EE9975C36A926F29A43E8B6FAE9D4D9C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_31871EDDC6D7CAF677998B6FAE9C288C" xlink:to="loc_us-gaap_CommonStockMember_EE9975C36A926F29A43E8B6FAE9D4D9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9793BC4FE667D4DF62678B6FAE9D57B7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_31871EDDC6D7CAF677998B6FAE9C288C" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9793BC4FE667D4DF62678B6FAE9D57B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_B669CDE737E161FC0BC88B6FAE9D1409" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_31871EDDC6D7CAF677998B6FAE9C288C" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_B669CDE737E161FC0BC88B6FAE9D1409" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_2B051ED87000BB590A598B6FAE9EAE51" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_31871EDDC6D7CAF677998B6FAE9C288C" xlink:to="loc_us-gaap_RetainedEarningsMember_2B051ED87000BB590A598B6FAE9EAE51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_6F60125553199E0B09B38B6FAE9EEE06" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_A3F4F4A457B43093822A8B6FAE9B5F37" xlink:to="loc_us-gaap_StatementLineItems_6F60125553199E0B09B38B6FAE9EEE06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3F55480ECB81D1EF6E468B6FAE9E2485" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6F60125553199E0B09B38B6FAE9EEE06" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3F55480ECB81D1EF6E468B6FAE9E2485" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_CCB4EAD7BD5493BFE97E8B6FAE9E50E6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3F55480ECB81D1EF6E468B6FAE9E2485" xlink:to="loc_us-gaap_SharesOutstanding_CCB4EAD7BD5493BFE97E8B6FAE9E50E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_920381340E2E372311AE8B6FAE9F6821" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3F55480ECB81D1EF6E468B6FAE9E2485" xlink:to="loc_us-gaap_StockholdersEquity_920381340E2E372311AE8B6FAE9F6821" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2940A599692ECC79E2DD8B6FAE9FF2B6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3F55480ECB81D1EF6E468B6FAE9E2485" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2940A599692ECC79E2DD8B6FAE9FF2B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_B08BF7F5BA4C4B4E7D428B6FB25CF7AA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3F55480ECB81D1EF6E468B6FAE9E2485" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_B08BF7F5BA4C4B4E7D428B6FB25CF7AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4BFB2238736FE5BB8DBF8B6FAEA11DC3" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3F55480ECB81D1EF6E468B6FAE9E2485" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4BFB2238736FE5BB8DBF8B6FAEA11DC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_60358D4FEE3F9CE4A6EE8B6FAEA1776C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3F55480ECB81D1EF6E468B6FAE9E2485" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_60358D4FEE3F9CE4A6EE8B6FAEA1776C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount" xlink:label="loc_us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_8AA05A60ADC4B0A0E75D8B6FAEA2BC73" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3F55480ECB81D1EF6E468B6FAE9E2485" xlink:to="loc_us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_8AA05A60ADC4B0A0E75D8B6FAEA2BC73" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_AdjustmentsToAdditionalPaidInCapitalCommonStockAndWarrantsIssuedShares" xlink:label="loc_dare_AdjustmentsToAdditionalPaidInCapitalCommonStockAndWarrantsIssuedShares_02EE51BC72EE44F23ACA8B6FAEA236D0" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3F55480ECB81D1EF6E468B6FAE9E2485" xlink:to="loc_dare_AdjustmentsToAdditionalPaidInCapitalCommonStockAndWarrantsIssuedShares_02EE51BC72EE44F23ACA8B6FAEA236D0" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_AdjustmentsToAdditionalPaidInCapitalCommonStockAndWarrantsIssued" xlink:label="loc_dare_AdjustmentsToAdditionalPaidInCapitalCommonStockAndWarrantsIssued_863F0428610B7AD5EBD38B6FAEA260F2" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3F55480ECB81D1EF6E468B6FAE9E2485" xlink:to="loc_dare_AdjustmentsToAdditionalPaidInCapitalCommonStockAndWarrantsIssued_863F0428610B7AD5EBD38B6FAEA260F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_4FBA5B9F086B6C03DD768B6FAEA2CE65" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3F55480ECB81D1EF6E468B6FAE9E2485" xlink:to="loc_us-gaap_NetIncomeLoss_4FBA5B9F086B6C03DD768B6FAEA2CE65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_B0E091BBFECD596837438B6FAEA2B4BD" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3F55480ECB81D1EF6E468B6FAE9E2485" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_B0E091BBFECD596837438B6FAEA2B4BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_B1C979487A100BB111688B6FAEA2F36D" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3F55480ECB81D1EF6E468B6FAE9E2485" xlink:to="loc_us-gaap_SharesOutstanding_B1C979487A100BB111688B6FAEA2F36D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_CCBCDFDC95C9C86BCB308B6FAEA3BF14" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3F55480ECB81D1EF6E468B6FAE9E2485" xlink:to="loc_us-gaap_StockholdersEquity_CCBCDFDC95C9C86BCB308B6FAEA3BF14" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:href="dare-20190630.xsd#dare_DocumentAndEntityInformationAbstract" xlink:label="loc_dare_DocumentAndEntityInformationAbstract_2EDCD025007315E04583720C2235A710" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_1B60FC890212C3CC8FE2720C223A31CA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_2EDCD025007315E04583720C2235A710" xlink:to="loc_dei_DocumentType_1B60FC890212C3CC8FE2720C223A31CA" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_C91B96610588A6369F95720C223ADAEF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_2EDCD025007315E04583720C2235A710" xlink:to="loc_dei_AmendmentFlag_C91B96610588A6369F95720C223ADAEF" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_B051D0B7A79F1107A821720C223BA228" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_2EDCD025007315E04583720C2235A710" xlink:to="loc_dei_DocumentPeriodEndDate_B051D0B7A79F1107A821720C223BA228" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_73CFAA96A126F30ABB3D720C223B6BB3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_2EDCD025007315E04583720C2235A710" xlink:to="loc_dei_DocumentFiscalYearFocus_73CFAA96A126F30ABB3D720C223B6BB3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_71A050169DD0A9FF285F720C223B6631" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_2EDCD025007315E04583720C2235A710" xlink:to="loc_dei_DocumentFiscalPeriodFocus_71A050169DD0A9FF285F720C223B6631" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_7AED388970DE8BC1C13B720C223B45DF" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_2EDCD025007315E04583720C2235A710" xlink:to="loc_dei_EntityRegistrantName_7AED388970DE8BC1C13B720C223B45DF" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_74B076A9F5EA8AE95318720C223CD8FB" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_2EDCD025007315E04583720C2235A710" xlink:to="loc_dei_EntityCentralIndexKey_74B076A9F5EA8AE95318720C223CD8FB" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_0765B7E978DD5822FE75720C223CCFA8" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_2EDCD025007315E04583720C2235A710" xlink:to="loc_dei_CurrentFiscalYearEndDate_0765B7E978DD5822FE75720C223CCFA8" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_C95071695F167B8F22C1720C223C0FDA" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_2EDCD025007315E04583720C2235A710" xlink:to="loc_dei_EntityFilerCategory_C95071695F167B8F22C1720C223C0FDA" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_E7A3B3432B71680FBD0B720C223CC959" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_2EDCD025007315E04583720C2235A710" xlink:to="loc_dei_EntitySmallBusiness_E7A3B3432B71680FBD0B720C223CC959" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_A8893BC5F3AE680EF2D9720C223D6896" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_2EDCD025007315E04583720C2235A710" xlink:to="loc_dei_EntityEmergingGrowthCompany_A8893BC5F3AE680EF2D9720C223D6896" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_F019616E4DCEDFAD6BE4720C223DD995" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_2EDCD025007315E04583720C2235A710" xlink:to="loc_dei_EntityExTransitionPeriod_F019616E4DCEDFAD6BE4720C223DD995" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_799446C3D5A99AEEE764720C223DC200" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_2EDCD025007315E04583720C2235A710" xlink:to="loc_dei_EntityShellCompany_799446C3D5A99AEEE764720C223DC200" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_8E5AAFA6664C70D2827D720C223D7BB4" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_2EDCD025007315E04583720C2235A710" xlink:to="loc_dei_EntityCurrentReportingStatus_8E5AAFA6664C70D2827D720C223D7BB4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_03F8139EF284CF48C34B720C223EC9FC" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_2EDCD025007315E04583720C2235A710" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_03F8139EF284CF48C34B720C223EC9FC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/GoingConcern" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_DF31327ED928534F9406C4F4D10CE146" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_774791C3ED2057D08400EF7FA2C6A932" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_DF31327ED928534F9406C4F4D10CE146" xlink:to="loc_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_774791C3ED2057D08400EF7FA2C6A932" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/GoingConcernAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6B6BE9B4D81E6B05C7B66D52EA5B2091" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_51EADE8B97AC278B9AA46D52EA5B9FCA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6B6BE9B4D81E6B05C7B66D52EA5B2091" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_51EADE8B97AC278B9AA46D52EA5B9FCA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_7CEFFF5465D919DDC8916D52EA5B734B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_51EADE8B97AC278B9AA46D52EA5B9FCA" xlink:to="loc_srt_ProductOrServiceAxis_7CEFFF5465D919DDC8916D52EA5B734B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_9EECFEEFA666A9A4A7506D52EA5B5235" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_7CEFFF5465D919DDC8916D52EA5B734B" xlink:to="loc_srt_ProductsAndServicesDomain_9EECFEEFA666A9A4A7506D52EA5B5235" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrantMember" xlink:label="loc_us-gaap_GrantMember_91FA625B5AA197D1BBAA6D52EA5B54E6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9EECFEEFA666A9A4A7506D52EA5B5235" xlink:to="loc_us-gaap_GrantMember_91FA625B5AA197D1BBAA6D52EA5B54E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8A7BA3A6C2CC1CCB7E036D52EA5B2B80" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_51EADE8B97AC278B9AA46D52EA5B9FCA" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8A7BA3A6C2CC1CCB7E036D52EA5B2B80" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_D728D2DFBCC6381234FA6D52EA5B7E8E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8A7BA3A6C2CC1CCB7E036D52EA5B2B80" xlink:to="loc_us-gaap_RelatedPartyDomain_D728D2DFBCC6381234FA6D52EA5B7E8E" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_NationalInstitutesOfHealthMember" xlink:label="loc_dare_NationalInstitutesOfHealthMember_508495C41378D0FC8B686D52EA5B0048" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_D728D2DFBCC6381234FA6D52EA5B7E8E" xlink:to="loc_dare_NationalInstitutesOfHealthMember_508495C41378D0FC8B686D52EA5B0048" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HealthCareTrustFundAxis" xlink:label="loc_us-gaap_HealthCareTrustFundAxis_9024E697C6EEF9EEF45F6D52EA5BC69E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_51EADE8B97AC278B9AA46D52EA5B9FCA" xlink:to="loc_us-gaap_HealthCareTrustFundAxis_9024E697C6EEF9EEF45F6D52EA5BC69E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HealthCareTrustFundNameDomain" xlink:label="loc_us-gaap_HealthCareTrustFundNameDomain_CEFC5E1803BF6046AD196D52EA5BA5F7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareTrustFundAxis_9024E697C6EEF9EEF45F6D52EA5BC69E" xlink:to="loc_us-gaap_HealthCareTrustFundNameDomain_CEFC5E1803BF6046AD196D52EA5BA5F7" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_EuniceKennedyShriverNationalInstituteOfChildHealthAndHumanDevelopmentMember" xlink:label="loc_dare_EuniceKennedyShriverNationalInstituteOfChildHealthAndHumanDevelopmentMember_12D40397C4A8580A15106D52EA632555" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareTrustFundNameDomain_CEFC5E1803BF6046AD196D52EA5BA5F7" xlink:to="loc_dare_EuniceKennedyShriverNationalInstituteOfChildHealthAndHumanDevelopmentMember_12D40397C4A8580A15106D52EA632555" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_3558151A87F073611B636D52EA637928" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_51EADE8B97AC278B9AA46D52EA5B9FCA" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_3558151A87F073611B636D52EA637928" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_B93577EA87FA69C5A75D6D52EA63811A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_3558151A87F073611B636D52EA637928" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_B93577EA87FA69C5A75D6D52EA63811A" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_SecondPhaseOfResearchAndAvailabilityOfFundsMember" xlink:label="loc_dare_SecondPhaseOfResearchAndAvailabilityOfFundsMember_DF450E5A27D6B8FA488C6D52EA63B7AB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_B93577EA87FA69C5A75D6D52EA63811A" xlink:to="loc_dare_SecondPhaseOfResearchAndAvailabilityOfFundsMember_DF450E5A27D6B8FA488C6D52EA63B7AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_216F1500BD0EDBF0B0266D52EA648E15" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_51EADE8B97AC278B9AA46D52EA5B9FCA" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_216F1500BD0EDBF0B0266D52EA648E15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9E4D11A2D13C7455FC476D52EA64E91D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_216F1500BD0EDBF0B0266D52EA648E15" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9E4D11A2D13C7455FC476D52EA64E91D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_DF0FAA86DAD4E600AFA36D52EA64F688" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_216F1500BD0EDBF0B0266D52EA648E15" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_DF0FAA86DAD4E600AFA36D52EA64F688" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_C6383C3A9AD9746E849C6D52EA64D4EC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_216F1500BD0EDBF0B0266D52EA648E15" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_C6383C3A9AD9746E849C6D52EA64D4EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_C69E4D2F7126695CD38E6D52EA64A59D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_216F1500BD0EDBF0B0266D52EA648E15" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_C69E4D2F7126695CD38E6D52EA64A59D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="loc_us-gaap_GrantsReceivable_D5E64146DD92E00E0C1D6D52EA642C56" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_216F1500BD0EDBF0B0266D52EA648E15" xlink:to="loc_us-gaap_GrantsReceivable_D5E64146DD92E00E0C1D6D52EA642C56" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_ReimbursementOfGrantExpensesReceivable" xlink:label="loc_dare_ReimbursementOfGrantExpensesReceivable_82D663772CEE1F2578786D52EA647669" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_216F1500BD0EDBF0B0266D52EA648E15" xlink:to="loc_dare_ReimbursementOfGrantExpensesReceivable_82D663772CEE1F2578786D52EA647669" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_C078979A20F8332065206D52EA64F3C7" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_216F1500BD0EDBF0B0266D52EA648E15" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_C078979A20F8332065206D52EA64F3C7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/GrantAward" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaap_ReceivablesAbstract_A2FB7F44FAFF509AA836C4BE72D78A68" xlink:type="locator" />
    <link:loc xlink:href="dare-20190630.xsd#dare_GrantAwardTextBlock" xlink:label="loc_dare_GrantAwardTextBlock_6876CE8B016D5220A983CCD5C3DD1E43" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_A2FB7F44FAFF509AA836C4BE72D78A68" xlink:to="loc_dare_GrantAwardTextBlock_6876CE8B016D5220A983CCD5C3DD1E43" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/GrantAwardAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaap_ReceivablesAbstract_FC06EF96BBD77C5DE4FA78071A9A23CA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1655896E38CDAC0C103C78071A9A1D94" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_FC06EF96BBD77C5DE4FA78071A9A23CA" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1655896E38CDAC0C103C78071A9A1D94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_F277B3843F86B08B689B78071A9ABC8D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1655896E38CDAC0C103C78071A9A1D94" xlink:to="loc_srt_ProductOrServiceAxis_F277B3843F86B08B689B78071A9ABC8D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_9FF123669E71341C3E5878071A9A0359" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_F277B3843F86B08B689B78071A9ABC8D" xlink:to="loc_srt_ProductsAndServicesDomain_9FF123669E71341C3E5878071A9A0359" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrantMember" xlink:label="loc_us-gaap_GrantMember_535B6950653C3CB0D76878071A9B275F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9FF123669E71341C3E5878071A9A0359" xlink:to="loc_us-gaap_GrantMember_535B6950653C3CB0D76878071A9B275F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HealthCareTrustFundAxis" xlink:label="loc_us-gaap_HealthCareTrustFundAxis_1830BCA3919CD5B3402A78071A9B4127" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1655896E38CDAC0C103C78071A9A1D94" xlink:to="loc_us-gaap_HealthCareTrustFundAxis_1830BCA3919CD5B3402A78071A9B4127" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HealthCareTrustFundNameDomain" xlink:label="loc_us-gaap_HealthCareTrustFundNameDomain_D24BE27C4ACE19EC368C78071A9BDB2C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareTrustFundAxis_1830BCA3919CD5B3402A78071A9B4127" xlink:to="loc_us-gaap_HealthCareTrustFundNameDomain_D24BE27C4ACE19EC368C78071A9BDB2C" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_EuniceKennedyShriverNationalInstituteOfChildHealthAndHumanDevelopmentMember" xlink:label="loc_dare_EuniceKennedyShriverNationalInstituteOfChildHealthAndHumanDevelopmentMember_612F83A37AD7C0A1506378071A9B6D90" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareTrustFundNameDomain_D24BE27C4ACE19EC368C78071A9BDB2C" xlink:to="loc_dare_EuniceKennedyShriverNationalInstituteOfChildHealthAndHumanDevelopmentMember_612F83A37AD7C0A1506378071A9B6D90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_F3D37C904704783795E078071A9C38BE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1655896E38CDAC0C103C78071A9A1D94" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_F3D37C904704783795E078071A9C38BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_076D258F647EC3CAB6BE78071A9CF74D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_F3D37C904704783795E078071A9C38BE" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_076D258F647EC3CAB6BE78071A9CF74D" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_SecondPhaseOfResearchAndAvailabilityOfFundsMember" xlink:label="loc_dare_SecondPhaseOfResearchAndAvailabilityOfFundsMember_C8C5003CF6E2C5E1895878071A9C940C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_076D258F647EC3CAB6BE78071A9CF74D" xlink:to="loc_dare_SecondPhaseOfResearchAndAvailabilityOfFundsMember_C8C5003CF6E2C5E1895878071A9C940C" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_RemainingPortionOfResearchAndAvailabilityOfFundsMember" xlink:label="loc_dare_RemainingPortionOfResearchAndAvailabilityOfFundsMember_F8C3157919E0751B775978071A9CD738" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_076D258F647EC3CAB6BE78071A9CF74D" xlink:to="loc_dare_RemainingPortionOfResearchAndAvailabilityOfFundsMember_F8C3157919E0751B775978071A9CD738" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_47DF55D11E5E40B7DBCD78071A9DC328" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1655896E38CDAC0C103C78071A9A1D94" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_47DF55D11E5E40B7DBCD78071A9DC328" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_6345B2EE67E3C86B791378071A9D8811" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_47DF55D11E5E40B7DBCD78071A9DC328" xlink:to="loc_us-gaap_RelatedPartyDomain_6345B2EE67E3C86B791378071A9D8811" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_NationalInstitutesOfHealthMember" xlink:label="loc_dare_NationalInstitutesOfHealthMember_D95D11A6E5184A962CDB78071A9DBD1D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_6345B2EE67E3C86B791378071A9D8811" xlink:to="loc_dare_NationalInstitutesOfHealthMember_D95D11A6E5184A962CDB78071A9DBD1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8DCF5FB7D002ACDE54A678071A9DF0C0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1655896E38CDAC0C103C78071A9A1D94" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8DCF5FB7D002ACDE54A678071A9DF0C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8E39C881385A31E8D52878071A9D2B52" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8DCF5FB7D002ACDE54A678071A9DF0C0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8E39C881385A31E8D52878071A9D2B52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="loc_us-gaap_GrantsReceivable_587FD73E2F59C11C343078071A9EB0BD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8DCF5FB7D002ACDE54A678071A9DF0C0" xlink:to="loc_us-gaap_GrantsReceivable_587FD73E2F59C11C343078071A9EB0BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_8CE9F1F05363B064D33E78071A9ED29B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8DCF5FB7D002ACDE54A678071A9DF0C0" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_8CE9F1F05363B064D33E78071A9ED29B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/LeasedProperties" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_4979DA12CA2B50E29C489358FF47E295" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_1A5F31D46D355DC3846132FE3A63A00E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4979DA12CA2B50E29C489358FF47E295" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_1A5F31D46D355DC3846132FE3A63A00E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/LeasedPropertiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_D3A51C7A906455CE83DE87D13565E416" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetRentableArea" xlink:label="loc_us-gaap_NetRentableArea_46106322944B0DF9615C87D135652A95" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_D3A51C7A906455CE83DE87D13565E416" xlink:to="loc_us-gaap_NetRentableArea_46106322944B0DF9615C87D135652A95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1084D4EB8852CA71C68187D135657FD6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_D3A51C7A906455CE83DE87D13565E416" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1084D4EB8852CA71C68187D135657FD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_14D1172847189E5CF24287D135658437" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_D3A51C7A906455CE83DE87D13565E416" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_14D1172847189E5CF24287D135658437" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseMinimumRentals_6CA74F59CB7AF5D3808D87D13565D232" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_D3A51C7A906455CE83DE87D13565E416" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseMinimumRentals_6CA74F59CB7AF5D3808D87D13565D232" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_PercentageOfIncreaseInAnnualBaseRent" xlink:label="loc_dare_PercentageOfIncreaseInAnnualBaseRent_DDA1722093063A74768F87D13565CF6B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_D3A51C7A906455CE83DE87D13565E416" xlink:to="loc_dare_PercentageOfIncreaseInAnnualBaseRent_DDA1722093063A74768F87D13565CF6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_D62277D2A42943F0F41287D81D065160" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_D3A51C7A906455CE83DE87D13565E416" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_D62277D2A42943F0F41287D81D065160" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6A5CA07BD61B000E42CD87D135654587" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_D3A51C7A906455CE83DE87D13565E416" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6A5CA07BD61B000E42CD87D135654587" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_A8625A5BD3C53B09E57587D13565E027" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_D3A51C7A906455CE83DE87D13565E416" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_A8625A5BD3C53B09E57587D13565E027" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_84A6D947C1DFFCEE01AA87D13565962C" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_D3A51C7A906455CE83DE87D13565E416" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_84A6D947C1DFFCEE01AA87D13565962C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_54C4EFAC4DB3779DCE9F87D135657741" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_D3A51C7A906455CE83DE87D13565E416" xlink:to="loc_us-gaap_OperatingLeaseCost_54C4EFAC4DB3779DCE9F87D135657741" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_021801878E381DDE7B8A87D13565802E" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_D3A51C7A906455CE83DE87D13565E416" xlink:to="loc_us-gaap_OperatingLeasePayments_021801878E381DDE7B8A87D13565802E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/LeasedPropertiesLeasedPropertiesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_C72CBFCA958858BBAF465D9DCCABA0A3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_C114029E7B17513681D7960F75ED5594" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C72CBFCA958858BBAF465D9DCCABA0A3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_C114029E7B17513681D7960F75ED5594" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_E960AAE60F40556EA85F7349097F00F2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C72CBFCA958858BBAF465D9DCCABA0A3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_E960AAE60F40556EA85F7349097F00F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_040CAB722AC255B088BC89FEE170BB61" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C72CBFCA958858BBAF465D9DCCABA0A3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_040CAB722AC255B088BC89FEE170BB61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_D086BA805C1F56C581CFAAB23A4D76CA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C72CBFCA958858BBAF465D9DCCABA0A3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_D086BA805C1F56C581CFAAB23A4D76CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2CBF8640BC605DFB9B88506239A08E63" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C72CBFCA958858BBAF465D9DCCABA0A3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2CBF8640BC605DFB9B88506239A08E63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_072D13B4B9EF5FA38754E9ABA2E065C6" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C72CBFCA958858BBAF465D9DCCABA0A3" xlink:to="loc_us-gaap_OperatingLeaseLiability_072D13B4B9EF5FA38754E9ABA2E065C6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/LeasedPropertiesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_A7AFD0EFF28D5F1599CF3E6689F5D865" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_C80FB35C25765DC6A026019E67E3693A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_A7AFD0EFF28D5F1599CF3E6689F5D865" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_C80FB35C25765DC6A026019E67E3693A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_892B5EC6526F5B59B10039AA9DAC8452" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_F9037B3123D052DCA0C5CD48F59DF8EF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_892B5EC6526F5B59B10039AA9DAC8452" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_F9037B3123D052DCA0C5CD48F59DF8EF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/NetLossPerSharePotentialDilutiveOutstandingSecuritiesExcludedFromDilutedNetLossPerCommonShareDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_711C30A4F92B7D190CED6D52E9535AA0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9BDB42DBDA238E4DBB596D52E953A6CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_711C30A4F92B7D190CED6D52E9535AA0" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9BDB42DBDA238E4DBB596D52E953A6CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_54BB2834DB4DBD6BCA1F6D52E953F13C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9BDB42DBDA238E4DBB596D52E953A6CB" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_54BB2834DB4DBD6BCA1F6D52E953F13C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_447AF40BE95F649A9D386D52E95471FB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_54BB2834DB4DBD6BCA1F6D52E953F13C" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_447AF40BE95F649A9D386D52E95471FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_63898290C78FD7CAEC566D52E954E914" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_447AF40BE95F649A9D386D52E95471FB" xlink:to="loc_us-gaap_EmployeeStockOptionMember_63898290C78FD7CAEC566D52E954E914" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_B71BE63BEEE944C2367D6D52E954DFF8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_447AF40BE95F649A9D386D52E95471FB" xlink:to="loc_us-gaap_WarrantMember_B71BE63BEEE944C2367D6D52E954DFF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_E7C252C5678F2865C8246D52E9547967" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9BDB42DBDA238E4DBB596D52E953A6CB" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_E7C252C5678F2865C8246D52E9547967" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5105188C94B7735FA6A16D52E954CC08" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_E7C252C5678F2865C8246D52E9547967" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5105188C94B7735FA6A16D52E954CC08" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_B3796063942255018FFFBC589346BDEC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_01CE7DEDA6645C2295761A6575145B93" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_B3796063942255018FFFBC589346BDEC" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_01CE7DEDA6645C2295761A6575145B93" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/OrganizationAndDescriptionOfBusiness" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_78D5848595855FA7AE59DE5E2E00BE78" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_FC215CD122245A0C8E3A5037040021E9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_78D5848595855FA7AE59DE5E2E00BE78" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_FC215CD122245A0C8E3A5037040021E9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/OrganizationAndDescriptionOfBusinessAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1BC6A65164EC3EA547A95E776956DFE2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_5A7709594452461163625E776967FDB0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1BC6A65164EC3EA547A95E776956DFE2" xlink:to="loc_us-gaap_NumberOfOperatingSegments_5A7709594452461163625E776967FDB0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_095D3B6D7C7D58299E1627EFCA77819B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_43B32258FEB757DC965CFFCCFA9A6124" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_095D3B6D7C7D58299E1627EFCA77819B" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_43B32258FEB757DC965CFFCCFA9A6124" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_CD5C8E004EA075D9FA1678071B0DF24A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_514665E902E8CF33929878071B0E0532" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_CD5C8E004EA075D9FA1678071B0DF24A" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_514665E902E8CF33929878071B0E0532" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_D976E7AE2CF00232181978071B0E68D2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_514665E902E8CF33929878071B0E0532" xlink:to="loc_us-gaap_PlanNameAxis_D976E7AE2CF00232181978071B0E68D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_9DDC3B35686E55DA0D6178071B0E1D41" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_D976E7AE2CF00232181978071B0E68D2" xlink:to="loc_us-gaap_PlanNameDomain_9DDC3B35686E55DA0D6178071B0E1D41" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_TwoThousandAndFifteenStockIncentivePlanMember" xlink:label="loc_dare_TwoThousandAndFifteenStockIncentivePlanMember_5C57066E292D285B3E1978071B0E4656" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9DDC3B35686E55DA0D6178071B0E1D41" xlink:to="loc_dare_TwoThousandAndFifteenStockIncentivePlanMember_5C57066E292D285B3E1978071B0E4656" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_TwoThousandAndFourteenEmployeeStockPurchasePlanMember" xlink:label="loc_dare_TwoThousandAndFourteenEmployeeStockPurchasePlanMember_31829F82667CBF8C8AFD78071B0FDCD4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9DDC3B35686E55DA0D6178071B0E1D41" xlink:to="loc_dare_TwoThousandAndFourteenEmployeeStockPurchasePlanMember_31829F82667CBF8C8AFD78071B0FDCD4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_F8F39A5165424763C5F778071B0F89C9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_514665E902E8CF33929878071B0E0532" xlink:to="loc_us-gaap_AwardTypeAxis_F8F39A5165424763C5F778071B0F89C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_478BFA23697F50EA512578071B0F6C27" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_F8F39A5165424763C5F778071B0F89C9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_478BFA23697F50EA512578071B0F6C27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_D2425F7E8F4F2379525678071B10340B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_478BFA23697F50EA512578071B0F6C27" xlink:to="loc_us-gaap_EmployeeStockOptionMember_D2425F7E8F4F2379525678071B10340B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_E098B8DA014F08AA312A78071B10512E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_478BFA23697F50EA512578071B0F6C27" xlink:to="loc_us-gaap_RestrictedStockMember_E098B8DA014F08AA312A78071B10512E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_AEE17DCE38D004C30D4C78071B10E487" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_514665E902E8CF33929878071B0E0532" xlink:to="loc_dei_LegalEntityAxis_AEE17DCE38D004C30D4C78071B10E487" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_50B3045CE0B52741848478071B1057F1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_AEE17DCE38D004C30D4C78071B10E487" xlink:to="loc_dei_EntityDomain_50B3045CE0B52741848478071B1057F1" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_PrivateDareMember" xlink:label="loc_dare_PrivateDareMember_DCE39D2318ADB58E9AC178071B109D47" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_50B3045CE0B52741848478071B1057F1" xlink:to="loc_dare_PrivateDareMember_DCE39D2318ADB58E9AC178071B109D47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0AE8B6F2FF272A9F6F8978071B110CBE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_514665E902E8CF33929878071B0E0532" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0AE8B6F2FF272A9F6F8978071B110CBE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_60FCE851A61B0D22ACA878071B11A1A7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0AE8B6F2FF272A9F6F8978071B110CBE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_60FCE851A61B0D22ACA878071B11A1A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_BBDD03E2CE24EED34C7C78071B119E9F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0AE8B6F2FF272A9F6F8978071B110CBE" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_BBDD03E2CE24EED34C7C78071B119E9F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1C7ADDA2E8185CEC996D78071B11420F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0AE8B6F2FF272A9F6F8978071B110CBE" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1C7ADDA2E8185CEC996D78071B11420F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_2CDF900943E7B604507C78071B119F62" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0AE8B6F2FF272A9F6F8978071B110CBE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_2CDF900943E7B604507C78071B119F62" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_DBB491C57AF1DEBE0FF678071B120A20" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0AE8B6F2FF272A9F6F8978071B110CBE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_DBB491C57AF1DEBE0FF678071B120A20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease_215A3D22D1652520B45D78071B12BC27" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0AE8B6F2FF272A9F6F8978071B110CBE" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease_215A3D22D1652520B45D78071B12BC27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_2FBB9910BBEAB761386C78071B1237E3" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0AE8B6F2FF272A9F6F8978071B110CBE" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_2FBB9910BBEAB761386C78071B1237E3" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_WeightedAverageAmortizationPeriod" xlink:label="loc_dare_WeightedAverageAmortizationPeriod_A0396191BCF261CEB98A78071B1296F8" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0AE8B6F2FF272A9F6F8978071B110CBE" xlink:to="loc_dare_WeightedAverageAmortizationPeriod_A0396191BCF261CEB98A78071B1296F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_DC7B422A8ADED2C5F2CE78071B12B8C9" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0AE8B6F2FF272A9F6F8978071B110CBE" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_DC7B422A8ADED2C5F2CE78071B12B8C9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesOptionPricingModelForStockOptionsGrantedToEmployeesAndDirectorsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_FF84B4A3C9FF575AA49C2DC50163B4F5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7932F9E7D6055092815608A5A42F9353" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_FF84B4A3C9FF575AA49C2DC50163B4F5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7932F9E7D6055092815608A5A42F9353" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_701DB48913EF5357B77F7FDCD401B7C2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_FF84B4A3C9FF575AA49C2DC50163B4F5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_701DB48913EF5357B77F7FDCD401B7C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_9C1A5A001D4B54B88E70024467A72FE5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_FF84B4A3C9FF575AA49C2DC50163B4F5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_9C1A5A001D4B54B88E70024467A72FE5" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:label="loc_dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_F826AB7414D552319F2D1DAC9D0346BD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_FF84B4A3C9FF575AA49C2DC50163B4F5" xlink:to="loc_dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_F826AB7414D552319F2D1DAC9D0346BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_A29D32EA88695212A0ED8830FAA82625" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_FF84B4A3C9FF575AA49C2DC50163B4F5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_A29D32EA88695212A0ED8830FAA82625" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5C72EE9B53655FD4ABD53DC5D5534431" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_FF84B4A3C9FF575AA49C2DC50163B4F5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5C72EE9B53655FD4ABD53DC5D5534431" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockBasedCompensationSummaryOfRecognizedStockBasedCompensationExpenseRelatedToStockOptionsGrantedToEmployeesAndDirectorsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4A436152E437063225566D52E9B6640B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_A37D537168FC2631BB636D52E9B6B68A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4A436152E437063225566D52E9B6640B" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_A37D537168FC2631BB636D52E9B6B68A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_7B7CBA4A3F9F3A9E8DFC6D52E9B65984" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_A37D537168FC2631BB636D52E9B6B68A" xlink:to="loc_us-gaap_AwardTypeAxis_7B7CBA4A3F9F3A9E8DFC6D52E9B65984" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F4A449490693E6C995BF6D52E9B76D8D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7B7CBA4A3F9F3A9E8DFC6D52E9B65984" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F4A449490693E6C995BF6D52E9B76D8D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_F9683919EFCF79397B776D52E9B7EF92" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F4A449490693E6C995BF6D52E9B76D8D" xlink:to="loc_us-gaap_EmployeeStockOptionMember_F9683919EFCF79397B776D52E9B7EF92" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_E57AF9FA462BDF24F9806D52E9B7FDD5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_A37D537168FC2631BB636D52E9B6B68A" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_E57AF9FA462BDF24F9806D52E9B7FDD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_D5174071889B94C41D236D52E9B76728" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_E57AF9FA462BDF24F9806D52E9B7FDD5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_D5174071889B94C41D236D52E9B76728" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_9A3F78E83DDAF94383416D52E9B8BD46" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D5174071889B94C41D236D52E9B76728" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_9A3F78E83DDAF94383416D52E9B8BD46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_9DE0FCC49AFA4099BDD76D52E9B8EB66" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D5174071889B94C41D236D52E9B76728" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_9DE0FCC49AFA4099BDD76D52E9B8EB66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_69482650FDEAD6C154116D52E9B872D0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_A37D537168FC2631BB636D52E9B6B68A" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_69482650FDEAD6C154116D52E9B872D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_720A5EAA695713175DA46D52E9B8D0CF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_69482650FDEAD6C154116D52E9B872D0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_720A5EAA695713175DA46D52E9B8D0CF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockBasedCompensationSummaryOfStockOptionActivityForAmended2014PlanAndRelatedInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40205D1A594686018594865C0E0C98F6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1BA443E41EFE503DE841865C0E0CDA2D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40205D1A594686018594865C0E0C98F6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1BA443E41EFE503DE841865C0E0CDA2D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_B0632701CF95A2384886865C0E0C207D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1BA443E41EFE503DE841865C0E0CDA2D" xlink:to="loc_dei_LegalEntityAxis_B0632701CF95A2384886865C0E0C207D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_203CF7377A77E2D5394A865C0E0C49AA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_B0632701CF95A2384886865C0E0C207D" xlink:to="loc_dei_EntityDomain_203CF7377A77E2D5394A865C0E0C49AA" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_PrivateDareMember" xlink:label="loc_dare_PrivateDareMember_0BDA779B5B444FE258BA865C0E0D5053" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_203CF7377A77E2D5394A865C0E0C49AA" xlink:to="loc_dare_PrivateDareMember_0BDA779B5B444FE258BA865C0E0D5053" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_A265480F395B83DDBC55865C0E0DA7DF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1BA443E41EFE503DE841865C0E0CDA2D" xlink:to="loc_us-gaap_PlanNameAxis_A265480F395B83DDBC55865C0E0DA7DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_F2A0F307C5F736625AF5865C0E0D7EA4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_A265480F395B83DDBC55865C0E0DA7DF" xlink:to="loc_us-gaap_PlanNameDomain_F2A0F307C5F736625AF5865C0E0D7EA4" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_TwoThousandAndFifteenStockIncentivePlanMember" xlink:label="loc_dare_TwoThousandAndFifteenStockIncentivePlanMember_A09A6196A725CD7522BD865C0E0D9B1A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_F2A0F307C5F736625AF5865C0E0D7EA4" xlink:to="loc_dare_TwoThousandAndFifteenStockIncentivePlanMember_A09A6196A725CD7522BD865C0E0D9B1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_12F9273A4AE1D453DD5F865C0E0E8D25" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1BA443E41EFE503DE841865C0E0CDA2D" xlink:to="loc_us-gaap_AwardTypeAxis_12F9273A4AE1D453DD5F865C0E0E8D25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1C3AE6BDC8E4BF34F01B865C0E0EB8B5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_12F9273A4AE1D453DD5F865C0E0E8D25" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1C3AE6BDC8E4BF34F01B865C0E0EB8B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_C0D2D786D7C1A5363C62865C0E0FD86C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1C3AE6BDC8E4BF34F01B865C0E0EB8B5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_C0D2D786D7C1A5363C62865C0E0FD86C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BB49971B6B7754989465865C0E0F7241" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1BA443E41EFE503DE841865C0E0CDA2D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BB49971B6B7754989465865C0E0F7241" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D9A9BC320862C46A804C865C0E0F609E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BB49971B6B7754989465865C0E0F7241" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D9A9BC320862C46A804C865C0E0F609E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7B91F1F506B83CD2AECB865C0E0FFDBC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D9A9BC320862C46A804C865C0E0F609E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7B91F1F506B83CD2AECB865C0E0FFDBC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_EDB7F6D4101931318769865C0E108ABE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D9A9BC320862C46A804C865C0E0F609E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_EDB7F6D4101931318769865C0E108ABE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2B03E75D60AAB7B38FC3865C0E10581F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D9A9BC320862C46A804C865C0E0F609E" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2B03E75D60AAB7B38FC3865C0E10581F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_5868494C6DFFBA84B9E6865C0E105BC0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D9A9BC320862C46A804C865C0E0F609E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_5868494C6DFFBA84B9E6865C0E105BC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_DB654CF8009A0FA37AE4865C0E10A77A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D9A9BC320862C46A804C865C0E0F609E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_DB654CF8009A0FA37AE4865C0E10A77A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_93D22FAF60337B8881E2865C0E10E746" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D9A9BC320862C46A804C865C0E0F609E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_93D22FAF60337B8881E2865C0E10E746" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_B95FC75F6B5EB2296166865C0E110005" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_D9A9BC320862C46A804C865C0E0F609E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_B95FC75F6B5EB2296166865C0E110005" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_C567AFAB4A1E7B2EEF65865C0E116974" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BB49971B6B7754989465865C0E0F7241" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_C567AFAB4A1E7B2EEF65865C0E116974" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5D0F747F18C3941C0547865C0E11D9BC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_C567AFAB4A1E7B2EEF65865C0E116974" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5D0F747F18C3941C0547865C0E11D9BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7C3903BFC828FF19F5DA865C0E11799D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_C567AFAB4A1E7B2EEF65865C0E116974" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7C3903BFC828FF19F5DA865C0E11799D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_26EF1CFE6198804D4251865C0E11BA73" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_C567AFAB4A1E7B2EEF65865C0E116974" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_26EF1CFE6198804D4251865C0E11BA73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_64F83E078EA7BFE8FE96865C0E124874" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_C567AFAB4A1E7B2EEF65865C0E116974" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_64F83E078EA7BFE8FE96865C0E124874" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_A0499CB2AF341A040FCE865C0E12BD3E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_C567AFAB4A1E7B2EEF65865C0E116974" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_A0499CB2AF341A040FCE865C0E12BD3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3C8273D8CBA5A4824CF5865C0E12125A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_C567AFAB4A1E7B2EEF65865C0E116974" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3C8273D8CBA5A4824CF5865C0E12125A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_E7791DF4D39EF7B74E8C865C0E129A70" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_C567AFAB4A1E7B2EEF65865C0E116974" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_E7791DF4D39EF7B74E8C865C0E129A70" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_FE80EE6FDF235208936FD9B2610A54B4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8B6D6B437E975B46959BB2D0E246A1D1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_FE80EE6FDF235208936FD9B2610A54B4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8B6D6B437E975B46959BB2D0E246A1D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_52B102DEDA16541F89C5D0E6CEFA6201" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_FE80EE6FDF235208936FD9B2610A54B4" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_52B102DEDA16541F89C5D0E6CEFA6201" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_EAC054E600655DE9AEAB3E5F480A3079" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_FE80EE6FDF235208936FD9B2610A54B4" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_EAC054E600655DE9AEAB3E5F480A3079" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_DFB639E118A95852B1DC6FD590DA415C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1BCF9F685E4B58B6989B4E5A56E13C8F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_DFB639E118A95852B1DC6FD590DA415C" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1BCF9F685E4B58B6989B4E5A56E13C8F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockholdersEquityAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_BB1CB57381F127144D268B6FD36DD338" xlink:type="locator" />
    <link:loc xlink:href="dare-20190630.xsd#dare_StockholdersEquityTable" xlink:label="loc_dare_StockholdersEquityTable_5D45154D634295EFF0858B6FD36D9A11" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_BB1CB57381F127144D268B6FD36DD338" xlink:to="loc_dare_StockholdersEquityTable_5D45154D634295EFF0858B6FD36D9A11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_C4D21A9C27F1C21938E08B6FD36D8181" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityTable_5D45154D634295EFF0858B6FD36D9A11" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_C4D21A9C27F1C21938E08B6FD36D8181" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_A22A502617E824B33A8E8B6FD36DBDDA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_C4D21A9C27F1C21938E08B6FD36D8181" xlink:to="loc_us-gaap_TypeOfAdoptionMember_A22A502617E824B33A8E8B6FD36DBDDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201711Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201711Member_A0146588574C7621B0D28B6FD36DC100" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_A22A502617E824B33A8E8B6FD36DBDDA" xlink:to="loc_us-gaap_AccountingStandardsUpdate201711Member_A0146588574C7621B0D28B6FD36DC100" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_323D23335B44D181BC6F8B6FD36D93C8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityTable_5D45154D634295EFF0858B6FD36D9A11" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_323D23335B44D181BC6F8B6FD36D93C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_EAC28790EB64CA571DEB8B6FD36D8B1B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_323D23335B44D181BC6F8B6FD36D93C8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_EAC28790EB64CA571DEB8B6FD36D8B1B" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_WarrantsExpiringOnFebruaryFifteenTwoThousandTwentyThreeMember" xlink:label="loc_dare_WarrantsExpiringOnFebruaryFifteenTwoThousandTwentyThreeMember_E965608F9764FB087E408B6FD36DD8A5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_EAC28790EB64CA571DEB8B6FD36D8B1B" xlink:to="loc_dare_WarrantsExpiringOnFebruaryFifteenTwoThousandTwentyThreeMember_E965608F9764FB087E408B6FD36DD8A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_714ED3D5617F28201EAF8B6FD36DCA40" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityTable_5D45154D634295EFF0858B6FD36D9A11" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_714ED3D5617F28201EAF8B6FD36DCA40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_743F5CB0BDF0B773F4E68B6FD36D0179" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_714ED3D5617F28201EAF8B6FD36DCA40" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_743F5CB0BDF0B773F4E68B6FD36D0179" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaap_OverAllotmentOptionMember_8E0E9910F744357DE0388B6FD36D788D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_743F5CB0BDF0B773F4E68B6FD36D0179" xlink:to="loc_us-gaap_OverAllotmentOptionMember_8E0E9910F744357DE0388B6FD36D788D" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_PublicStockOfferingMember" xlink:label="loc_dare_PublicStockOfferingMember_B7A0DA44E04EE01018C58B6FD36D31F8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_743F5CB0BDF0B773F4E68B6FD36D0179" xlink:to="loc_dare_PublicStockOfferingMember_B7A0DA44E04EE01018C58B6FD36D31F8" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_StockholdersEquityLineItems" xlink:label="loc_dare_StockholdersEquityLineItems_3C9647CD26CC617AEC828B6FD36D8919" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityTable_5D45154D634295EFF0858B6FD36D9A11" xlink:to="loc_dare_StockholdersEquityLineItems_3C9647CD26CC617AEC828B6FD36D8919" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_GrossProceedsFromIssuanceOfCommonStock" xlink:label="loc_dare_GrossProceedsFromIssuanceOfCommonStock_5AF9D10A9736F08F38638B6FD36D4F27" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_3C9647CD26CC617AEC828B6FD36D8919" xlink:to="loc_dare_GrossProceedsFromIssuanceOfCommonStock_5AF9D10A9736F08F38638B6FD36D4F27" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_PercentageOfAggregateCommission" xlink:label="loc_dare_PercentageOfAggregateCommission_F6F73243D93E3C2980088B6FD36D9837" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_3C9647CD26CC617AEC828B6FD36D8919" xlink:to="loc_dare_PercentageOfAggregateCommission_F6F73243D93E3C2980088B6FD36D9837" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7D931EBDCEE712349F3C8B6FD36DCDF2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_3C9647CD26CC617AEC828B6FD36D8919" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7D931EBDCEE712349F3C8B6FD36DCDF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_8C3D3A6C3F9CE19D44FA8B6FD36D0206" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_3C9647CD26CC617AEC828B6FD36D8919" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_8C3D3A6C3F9CE19D44FA8B6FD36D0206" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_87AA5F3BA749CB1A18548B6FD36D4777" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_3C9647CD26CC617AEC828B6FD36D8919" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_87AA5F3BA749CB1A18548B6FD36D4777" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_10DA379D4E459D6FC60E8B6FD36D25C4" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_3C9647CD26CC617AEC828B6FD36D8919" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_10DA379D4E459D6FC60E8B6FD36D25C4" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_UnderwritersOptionToPurchaseAdditionalSharesOfCommonStockPeriod" xlink:label="loc_dare_UnderwritersOptionToPurchaseAdditionalSharesOfCommonStockPeriod_A8C439607C34AC537A8B8B6FD36D6A55" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_3C9647CD26CC617AEC828B6FD36D8919" xlink:to="loc_dare_UnderwritersOptionToPurchaseAdditionalSharesOfCommonStockPeriod_A8C439607C34AC537A8B8B6FD36D6A55" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_UnderwritersOptionToPurchaseAdditionalShares" xlink:label="loc_dare_UnderwritersOptionToPurchaseAdditionalShares_E475BDC2875473EA85A58B6FD36DF2C2" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_3C9647CD26CC617AEC828B6FD36D8919" xlink:to="loc_dare_UnderwritersOptionToPurchaseAdditionalShares_E475BDC2875473EA85A58B6FD36DF2C2" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_GrossProceedsFromOfferingOfCommonStockAndWarrants" xlink:label="loc_dare_GrossProceedsFromOfferingOfCommonStockAndWarrants_496FA365D812DD499E298B6FD36D0025" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_3C9647CD26CC617AEC828B6FD36D8919" xlink:to="loc_dare_GrossProceedsFromOfferingOfCommonStockAndWarrants_496FA365D812DD499E298B6FD36D0025" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_FD29875E61840CFADAF68B6FD36D09D1" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_3C9647CD26CC617AEC828B6FD36D8919" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_FD29875E61840CFADAF68B6FD36D09D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5F4F281DD89E3CD706758B6FD36D0CA0" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_3C9647CD26CC617AEC828B6FD36D8919" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5F4F281DD89E3CD706758B6FD36D0CA0" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_EstimatedFairValueOfWarrantsRecordedInEquity" xlink:label="loc_dare_EstimatedFairValueOfWarrantsRecordedInEquity_30857EFADD67571259728B6FD36DCE36" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_3C9647CD26CC617AEC828B6FD36D8919" xlink:to="loc_dare_EstimatedFairValueOfWarrantsRecordedInEquity_30857EFADD67571259728B6FD36DCE36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount" xlink:label="loc_us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_09F24EB06E9082A95BAB8B6FD36D5D21" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_3C9647CD26CC617AEC828B6FD36D8919" xlink:to="loc_us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_09F24EB06E9082A95BAB8B6FD36D5D21" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_NumberOfCommonStockWarrantsExercised" xlink:label="loc_dare_NumberOfCommonStockWarrantsExercised_F3F6567BFBB804B7728E8B6FD36D38E7" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_3C9647CD26CC617AEC828B6FD36D8919" xlink:to="loc_dare_NumberOfCommonStockWarrantsExercised_F3F6567BFBB804B7728E8B6FD36D38E7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockholdersEquityScheduleOfCommonStockWarrantsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_14B5BFFB0214C67A644B6D52E9986F8C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_894F467B9053467DE1956D52E998F00A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_14B5BFFB0214C67A644B6D52E9986F8C" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_894F467B9053467DE1956D52E998F00A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_5EA6D1172A73F93A42A86D52E998D5FA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_894F467B9053467DE1956D52E998F00A" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_5EA6D1172A73F93A42A86D52E998D5FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_0B823F23CFAAFB9B62016D52E9998E62" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_5EA6D1172A73F93A42A86D52E998D5FA" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_0B823F23CFAAFB9B62016D52E9998E62" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_WarrantsExpiringOnDecemberOneTwoThousandTwentyOneMember" xlink:label="loc_dare_WarrantsExpiringOnDecemberOneTwoThousandTwentyOneMember_0024FA9F0FCE3B3D334B6D52E999D19B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_0B823F23CFAAFB9B62016D52E9998E62" xlink:to="loc_dare_WarrantsExpiringOnDecemberOneTwoThousandTwentyOneMember_0024FA9F0FCE3B3D334B6D52E999D19B" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_WarrantsExpiringOnDecemberSixTwoThousandTwentyOneMember" xlink:label="loc_dare_WarrantsExpiringOnDecemberSixTwoThousandTwentyOneMember_48F387ED3BCC11EAAB356D52E9995787" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_0B823F23CFAAFB9B62016D52E9998E62" xlink:to="loc_dare_WarrantsExpiringOnDecemberSixTwoThousandTwentyOneMember_48F387ED3BCC11EAAB356D52E9995787" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_WarrantsExpiringOnJanuaryEightTwoThousandTwentyMember" xlink:label="loc_dare_WarrantsExpiringOnJanuaryEightTwoThousandTwentyMember_EC1FF5ACCCD5D5F45B706D52E9998301" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_0B823F23CFAAFB9B62016D52E9998E62" xlink:to="loc_dare_WarrantsExpiringOnJanuaryEightTwoThousandTwentyMember_EC1FF5ACCCD5D5F45B706D52E9998301" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_WarrantsExpiringOnAprilFourTwoThousandTwentySixMember" xlink:label="loc_dare_WarrantsExpiringOnAprilFourTwoThousandTwentySixMember_D07B800AD32050182F536D52E99A4403" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_0B823F23CFAAFB9B62016D52E9998E62" xlink:to="loc_dare_WarrantsExpiringOnAprilFourTwoThousandTwentySixMember_D07B800AD32050182F536D52E99A4403" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_WarrantsExpiringOnFebruaryFifteenTwoThousandTwentyThreeMember" xlink:label="loc_dare_WarrantsExpiringOnFebruaryFifteenTwoThousandTwentyThreeMember_C0BDD88798ECE3558C866D52E99A55BA" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_0B823F23CFAAFB9B62016D52E9998E62" xlink:to="loc_dare_WarrantsExpiringOnFebruaryFifteenTwoThousandTwentyThreeMember_C0BDD88798ECE3558C866D52E99A55BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_BD37FE611C764357EC6C6D52E99A27E3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_894F467B9053467DE1956D52E998F00A" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_BD37FE611C764357EC6C6D52E99A27E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_529FB235BCCE9DDDF0606D52E99A9280" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_BD37FE611C764357EC6C6D52E99A27E3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_529FB235BCCE9DDDF0606D52E99A9280" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_611770AE143C190FE3946D52E99A1C2B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_BD37FE611C764357EC6C6D52E99A27E3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_611770AE143C190FE3946D52E99A1C2B" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_ClassOfWarrantOrRightsWarrantsExpirationDate" xlink:label="loc_dare_ClassOfWarrantOrRightsWarrantsExpirationDate_C89B1CD0EB99D3470BC46D52E99AF597" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_BD37FE611C764357EC6C6D52E99A27E3" xlink:to="loc_dare_ClassOfWarrantOrRightsWarrantsExpirationDate_C89B1CD0EB99D3470BC46D52E99AF597" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_477C6C5CEE755F8B84666DCE660B3720" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_ED7AE697A5025E8B929ED9C53E407454" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_477C6C5CEE755F8B84666DCE660B3720" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_ED7AE697A5025E8B929ED9C53E407454" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_25459F96AD1D5F90822E4F87F4E937BA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_8C95ABB2DF745DDBA564C38D4BAC1F14" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_25459F96AD1D5F90822E4F87F4E937BA" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_8C95ABB2DF745DDBA564C38D4BAC1F14" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_63A6FD055EF8564FB487B59EA17378C5" xlink:type="locator" />
    <link:loc xlink:href="dare-20190630.xsd#dare_SignificantAccountingPoliciesTable" xlink:label="loc_dare_SignificantAccountingPoliciesTable_40577E5A38E154DCAD75C5B130F9614D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63A6FD055EF8564FB487B59EA17378C5" xlink:to="loc_dare_SignificantAccountingPoliciesTable_40577E5A38E154DCAD75C5B130F9614D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_209AC45F5E755D4099BC7980989D7CAF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_40577E5A38E154DCAD75C5B130F9614D" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_209AC45F5E755D4099BC7980989D7CAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_CFC94E094EDC5E2C97061DE81812010D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_209AC45F5E755D4099BC7980989D7CAF" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_CFC94E094EDC5E2C97061DE81812010D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_1EDEC70169415366995BBC3415215316" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_CFC94E094EDC5E2C97061DE81812010D" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_1EDEC70169415366995BBC3415215316" xlink:type="arc" />
    <link:loc xlink:href="dare-20190630.xsd#dare_SignificantAccountingPoliciesLineItems" xlink:label="loc_dare_SignificantAccountingPoliciesLineItems_AB1FA72B72255C4BBD63C9710624E4F1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_40577E5A38E154DCAD75C5B130F9614D" xlink:to="loc_dare_SignificantAccountingPoliciesLineItems_AB1FA72B72255C4BBD63C9710624E4F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_B6C4AA5F53135D578EB929FDCDC002F3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_AB1FA72B72255C4BBD63C9710624E4F1" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_B6C4AA5F53135D578EB929FDCDC002F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_E29D27230F9559618B917803F6FF7BFE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_AB1FA72B72255C4BBD63C9710624E4F1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_E29D27230F9559618B917803F6FF7BFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_8607D7D599C95535911B7476F183D0F3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_AB1FA72B72255C4BBD63C9710624E4F1" xlink:to="loc_us-gaap_OperatingLeaseLiability_8607D7D599C95535911B7476F183D0F3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_813630F74BB05A188BB9CB1E8A140C9C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ABE78533779F5A4DBEEE3F0E0C93A850" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_813630F74BB05A188BB9CB1E8A140C9C" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ABE78533779F5A4DBEEE3F0E0C93A850" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_8E63F5C76A515033BA493C45156336DD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_813630F74BB05A188BB9CB1E8A140C9C" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_8E63F5C76A515033BA493C45156336DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_52999C838DE858A2B4AC7E304CC9D7B0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_813630F74BB05A188BB9CB1E8A140C9C" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_52999C838DE858A2B4AC7E304CC9D7B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_D41DA061D14A508F92DFD52F0629BC69" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_813630F74BB05A188BB9CB1E8A140C9C" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_D41DA061D14A508F92DFD52F0629BC69" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
